<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60346</article-id><article-id pub-id-type="doi">10.7554/eLife.60346</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Peroxiredoxin promotes longevity and H<sub>2</sub>O<sub>2</sub>-resistance in yeast through redox-modulation of protein kinase A</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-160647"><name><surname>Roger</surname><given-names>Friederike</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195191"><name><surname>Picazo</surname><given-names>Cecilia</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-68929"><name><surname>Reiter</surname><given-names>Wolfgang</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1266-8975</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195192"><name><surname>Libiad</surname><given-names>Marouane</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160649"><name><surname>Asami</surname><given-names>Chikako</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160650"><name><surname>Hanzén</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160651"><name><surname>Gao</surname><given-names>Chunxia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160652"><name><surname>Lagniel</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160653"><name><surname>Welkenhuysen</surname><given-names>Niek</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160654"><name><surname>Labarre</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2646"><name><surname>Nyström</surname><given-names>Thomas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5489-2903</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund15"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160655"><name><surname>Grøtli</surname><given-names>Morten</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3621-4222</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-122932"><name><surname>Hartl</surname><given-names>Markus</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4970-7336</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-76760"><name><surname>Toledano</surname><given-names>Michel B</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3079-1179</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund12"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-159160"><name><surname>Molin</surname><given-names>Mikael</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3903-8503</contrib-id><email>mikael.molin@chalmers.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Chemistry and Molecular Biology, University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution>Department of Biology and Biological Engineering, Chalmers University of Technology</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff><aff id="aff3"><label>3</label><institution>Mass Spectrometry Facility, Department of Biochemistry, Max F. Perutz Laboratories, University of Vienna, Vienna BioCenter</institution><addr-line><named-content content-type="city">Vienna</named-content></addr-line><country>Austria</country></aff><aff id="aff4"><label>4</label><institution>Oxidative Stress and Cancer Laboratory, Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC)</institution><addr-line><named-content content-type="city">Gif sur Yvette</named-content></addr-line><country>France</country></aff><aff id="aff5"><label>5</label><institution>Oxidative Stress and Cancer Laboratory, Integrative Biology and Molecular Genetics Unit (SBIGEM)</institution><addr-line><named-content content-type="city">CEA Saclay</named-content></addr-line><country>France</country></aff><aff id="aff6"><label>6</label><institution>Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff><aff id="aff7"><label>7</label><institution>Department of Microbiology and Immunology, Institute for Biomedicine, Sahlgrenska Academy, University of Gothenburg</institution><addr-line><named-content content-type="city">Gothenburg</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Schuldiner</surname><given-names>Maya</given-names></name><role>Reviewing Editor</role><aff><institution>Weizmann Institute</institution><country>Israel</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution>Fred Hutchinson Cancer Research Center</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>14</day><month>07</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e60346</elocation-id><history><date date-type="received" iso-8601-date="2020-06-24"><day>24</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-07-08"><day>08</day><month>07</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Roger et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Roger et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-60346-v3.pdf"/><abstract><p>Peroxiredoxins are H<sub>2</sub>O<sub>2</sub> scavenging enzymes that also carry out H<sub>2</sub>O<sub>2</sub> signaling and chaperone functions. In yeast, the major cytosolic peroxiredoxin, Tsa1 is required for both promoting resistance to H<sub>2</sub>O<sub>2</sub> and extending lifespan upon caloric restriction. We show here that Tsa1 effects both these functions not by scavenging H<sub>2</sub>O<sub>2</sub>, but by repressing the nutrient signaling Ras-cAMP-PKA pathway at the level of the protein kinase A (PKA) enzyme. Tsa1 stimulates sulfenylation of cysteines in the PKA catalytic subunit by H<sub>2</sub>O<sub>2</sub> and a significant proportion of the catalytic subunits are glutathionylated on two cysteine residues. Redox modification of the conserved Cys243 inhibits the phosphorylation of a conserved Thr241 in the kinase activation loop and enzyme activity, and preventing Thr241 phosphorylation can overcome the H<sub>2</sub>O<sub>2</sub> sensitivity of Tsa1-deficient cells. Results support a model of aging where nutrient signaling pathways constitute hubs integrating information from multiple aging-related conduits, including a peroxiredoxin-dependent response to H<sub>2</sub>O<sub>2</sub>.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>aging</kwd><kwd>H<sub>2</sub>O<sub>2</sub> signalling</kwd><kwd>peroxiredoxin</kwd><kwd>protein kinase A</kwd><kwd>cysteine sulfenylation</kwd><kwd>glutathionylation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>S. cerevisiae</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><award-id>2017-778</award-id><principal-award-recipient><name><surname>Molin</surname><given-names>Mikael</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>NT 2011-5170</award-id><principal-award-recipient><name><surname>Molin</surname><given-names>Mikael</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004200</institution-id><institution>Stiftelsen Olle Engkvist Byggmästare</institution></institution-wrap></funding-source><award-id>20120620</award-id><principal-award-recipient><name><surname>Molin</surname><given-names>Mikael</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002805</institution-id><institution>Carl Tryggers Stiftelse för Vetenskaplig Forskning</institution></institution-wrap></funding-source><award-id>CTS 11:306</award-id><principal-award-recipient><name><surname>Molin</surname><given-names>Mikael</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002805</institution-id><institution>Carl Tryggers Stiftelse för Vetenskaplig Forskning</institution></institution-wrap></funding-source><award-id>CTS 13:277</award-id><principal-award-recipient><name><surname>Molin</surname><given-names>Mikael</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>PrxAge</award-id><principal-award-recipient><name><surname>Toledano</surname><given-names>Michel B</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ERRed2</award-id><principal-award-recipient><name><surname>Toledano</surname><given-names>Michel B</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>NT 2019-03937</award-id><principal-award-recipient><name><surname>Nyström</surname><given-names>Thomas</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004063</institution-id><institution>Knut och Alice Wallenbergs Stiftelse</institution></institution-wrap></funding-source><award-id>2017-0091</award-id><principal-award-recipient><name><surname>Nyström</surname><given-names>Thomas</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004063</institution-id><institution>Knut och Alice Wallenbergs Stiftelse</institution></institution-wrap></funding-source><award-id>2015-0272</award-id><principal-award-recipient><name><surname>Nyström</surname><given-names>Thomas</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The major cytosolic yeast peroxiredoxin Tsa1 controls aging and H<sub>2</sub>O<sub>2</sub>-resistance by inhibiting protein kinase A through a conserved cysteine in the catalytic subunit activation loop and not by scavenging H<sub>2</sub>O<sub>2</sub>.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Caloric restriction (CR) is an intervention that slows down aging and reduces the incidence of age-related disease from the unicellular baker’s yeast (<xref ref-type="bibr" rid="bib45">Lin et al., 2000</xref>) to rhesus monkeys (<xref ref-type="bibr" rid="bib50">Mattison et al., 2017</xref>). CR-induced reduced nutrient signaling via insulin/insulin-like growth factor (IGF-1), the target-of-rapamycin and/or protein kinase A pathways is intimately linked to lifespan extension (<xref ref-type="bibr" rid="bib23">Fontana et al., 2010</xref>; <xref ref-type="bibr" rid="bib39">Kenyon, 2010</xref>; <xref ref-type="bibr" rid="bib54">Molin and Demir, 2014</xref>; <xref ref-type="bibr" rid="bib57">Nyström et al., 2012</xref>). Of other things, reduced nutrient signaling mitigates age-related oxidative damage by increasing oxidative stress resistance in organisms from yeast to humans (<xref ref-type="bibr" rid="bib22">Fontán-Lozano et al., 2008</xref>; <xref ref-type="bibr" rid="bib31">Heilbronn et al., 2006</xref>; <xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>; <xref ref-type="bibr" rid="bib66">Schulz et al., 2007</xref>; <xref ref-type="bibr" rid="bib70">Sohal and Forster, 2014</xref>). Increased oxidative stress resistance appears as a common denominator of mechanisms by which nutrient signaling pathways dictate the anti-aging effects of CR and its health benefits (<xref ref-type="bibr" rid="bib2">Alic and Partridge, 2011</xref>; <xref ref-type="bibr" rid="bib23">Fontana et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Longo et al., 2012</xref>). Still very few specific targets of nutrient signaling that explain the beneficial effects of CR have been identified (<xref ref-type="bibr" rid="bib22">Fontán-Lozano et al., 2008</xref>).</p><p>Peroxiredoxins might constitute one such target, as this major family of peroxide-negating enzymes is required for lifespan promotion by CR and CR-mimetics (<xref ref-type="bibr" rid="bib14">De Haes et al., 2014</xref>; <xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>; <xref ref-type="bibr" rid="bib58">Oláhová and Veal, 2015</xref>). In worms, the CR-mimetic drug metformin extends lifespan in a manner dependent on the activity of Prdx-2 (<xref ref-type="bibr" rid="bib14">De Haes et al., 2014</xref>), and in flies, neuronal peroxiredoxin overexpression extends lifespan in the absence of caloric restriction (<xref ref-type="bibr" rid="bib43">Lee et al., 2009</xref>). In addition, CR increases both yeast H<sub>2</sub>O<sub>2</sub> tolerance and lifespan by stimulating the activity of the major 2-Cys peroxiredoxin, Tsa1 (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>), and the mild overexpression of Tsa1 potently extends lifespan by 40% (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>). As peroxiredoxins have been described as major peroxide scavenging enzymes, they may reduce the rate of aging by scavenging H<sub>2</sub>O<sub>2</sub>, which may also explain their requirement for the maintenance of genome stability (<xref ref-type="bibr" rid="bib54">Molin and Demir, 2014</xref>; <xref ref-type="bibr" rid="bib57">Nyström et al., 2012</xref>) and the premature accumulation of age-related tumors in PrxI-deficient mice (<xref ref-type="bibr" rid="bib55">Neumann et al., 2003</xref>). However, mild Tsa1 overexpression, although increasing lifespan, did not alter the rate at which mutations accumulate during aging (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>). Furthermore, CR reduced the increased mutation rate in Tsa1-deficient cells by 50% (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>) without extending their life-span (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>). We instead proposed that Tsa1 counteracts age-related protein damage by guiding Hsp70/104 molecular chaperones to proteins aggregating upon increased age and H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>).</p><p>Prx are obligate dimers carrying two catalytic residues, the peroxidatic Cys (C<sub>P</sub>, Cys48 in Tsa1) and the resolving Cys (C<sub>R</sub>, Cys171 in Tsa1). C<sub>P</sub> reduces H<sub>2</sub>O<sub>2</sub> and forms a sulfenic acid (-SOH), which condenses with the C<sub>R</sub> of the second Prx molecule into an inter-subunit disulfide, then reduced by thioredoxin. Once formed, the C<sub>P</sub>-SOH can also react with another H<sub>2</sub>O<sub>2</sub> molecule, which leads to formation of a sulfinic acid (-SO<sub>2</sub>H), instead of condensing into a disulfide. Sulfinylation inactivates the catalytic cycle, switching the enzyme function into a molecular chaperone by multimerisation (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Jang et al., 2004</xref>; <xref ref-type="bibr" rid="bib56">Noichri et al., 2015</xref>). Prxs can also signal H<sub>2</sub>O<sub>2</sub> by transfer of the oxidant signal to target proteins (<xref ref-type="bibr" rid="bib44">Leichert and Dick, 2015</xref>; <xref ref-type="bibr" rid="bib71">Stöcker et al., 2018a</xref>).</p><p>We recently showed that, in response to H<sub>2</sub>O<sub>2</sub>, Tsa1 and thioredoxin are required for the activation of the transcription factor Msn2, as it inhibits PKA-mediated Msn2 repression (<xref ref-type="bibr" rid="bib6">Bodvard et al., 2017</xref>). Here, we explored whether the modulation of PKA by Tsa1 had any relevance in its role in slowing down aging and in H<sub>2</sub>O<sub>2</sub> resistance. We show that both the premature aging and H<sub>2</sub>O<sub>2</sub> sensitivity of cells lacking Tsa1 is due to aberrant protein kinase A (PKA) activation, and not to defective H<sub>2</sub>O<sub>2</sub> scavenging per se. Similarly, a single extra copy of the <italic>TSA1</italic> gene extended life-span by mildly reducing PKA activity, without affecting H<sub>2</sub>O<sub>2</sub> scavenging. Tsa1 interacts with PKA at the level of its catalytic subunits. We identified a conserved Cys residue in the PKA catalytic subunit Tpk1 that is specifically required for Tsa1-mediated H<sub>2</sub>O<sub>2</sub> resistance. Tsa1-dependent oxidation of the catalytic subunit reduced enzyme activity and increased H<sub>2</sub>O<sub>2</sub> resistance in part through dephosphorylating a conserved threonine (Thr241) in the kinase activation loop. These results indicate that peroxiredoxins slow down the rate of aging through a unique role in kinase signaling, in addition to promoting proteostasis. They also suggest a novel mode of regulation of the conserved nutrient-sensing cascade PKA that bypasses conventional signaling via the second messenger cAMP, and impinges on both H<sub>2</sub>O<sub>2</sub> resistance and aging.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The effects of Tsa1 on longevity are mediated by the Ras-cAMP-PKA pathway</title><p>A single extra-copy of the <italic>TSA1</italic> gene, which encodes the major yeast cytosolic Prx, Tsa1, prolongs lifespan in the absence of caloric restriction (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>). To clarify the mechanism by which Tsa1 promotes this effect, we enquired whether PKA is involved, as this kinase antagonizes both longevity (<xref ref-type="bibr" rid="bib45">Lin et al., 2000</xref>) and resistance to H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>) and Tsa1 is required for decreasing PKA-dependent phosphorylation of the ‘general stress’ transcription factor Msn2 in response to H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib6">Bodvard et al., 2017</xref>). The high affinity cAMP-phosphodiesterase Pde2 degrades cAMP, and deletion of <italic>PDE2</italic> promotes PKA activation by increasing cAMP levels, downstream of Ras2 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib7">Broach, 2012</xref>; <xref ref-type="bibr" rid="bib16">Deprez et al., 2018</xref>; <xref ref-type="bibr" rid="bib65">Santangelo, 2006</xref>). Deletion of <italic>PDE2</italic> decreased the lifespan of the wild type strain by 45% (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), as previously shown (<xref ref-type="bibr" rid="bib45">Lin et al., 2000</xref>), and also prevented the increased lifespan conferred by mild overexpression of <italic>TSA1</italic> (compare <italic>pde2Δ</italic> and <italic>pde2Δ</italic> o/e <italic>TSA1</italic>), which indicates that PKA activity is dominant over Tsa1, and suggests that Tsa1 might slow down aging by decreasing PKA activity. Indeed, mild <italic>TSA1</italic> overexpression increased both the accumulation of the reserve carbohydrate glycogen (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), a diagnostic feature of low PKA activity, and the expression of the PKA-repressed Msn2/4 target Hsp12 (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The 2-cys peroxiredoxin Tsa1 slows down aging via inhibiting protein kinase A signaling.</title><p>(<bold>A</bold>) Overview of the Ras-cAMP-PKA signaling pathway. In blue stimulatory components and in red inhibitory. (<bold>B</bold>) Lifespans of cells expressing an extra copy of the <italic>TSA1</italic> gene or not (vector control) in combination with the deletion of <italic>PDE2</italic> to induce high PKA signaling (<italic>pde2Δ</italic>). (<bold>C</bold>) Accumulation of glycogen in vector control cells or cells expressing an extra copy of the <italic>TSA1</italic> gene as assayed by iodine vapor. (<bold>D</bold>) Expression of Hsp12 in the indicated mutant strains (n = 3). (<bold>E–F</bold>) Lifespan of cells lacking Tsa1, Ras2, Pde2 or combinations thereof.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig1-v3.tif"/></fig><p>We turned to cells lacking <italic>TSA1</italic>, which suffer a severely shortened lifespan (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>), asking whether this phenotype is linked to PKA. We combined the deletion of <italic>TSA1</italic> and <italic>RAS2</italic>, the latter largely abrogating the stimulation of PKA by glucose (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib65">Santangelo, 2006</xref>). Strikingly, Ras2 deficiency completely rescued the reduced lifespan (<xref ref-type="fig" rid="fig1">Figure 1E</xref>) of cells lacking Tsa1, and upon deletion of <italic>PDE2</italic> in these cells (<italic>ras2Δtsa1Δpde2Δ</italic>), this rescue was no longer visible (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). These data indicate that the shortened lifespan of <italic>tsa1Δ</italic> is due to aberrant activation of the Ras-PKA pathway, and as a corollary, that Tsa1 might inhibit this pathway. That Tsa1 deletion did not further reduce the lifespan of Pde2-deficient cells (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), further support the notion that Tsa1 influences longevity by repressing the Ras-PKA pathway.</p></sec><sec id="s2-2"><title>Tsa1 represses the Ras-cAMP-PKA pathway at the level of the PKA enzyme</title><p>Cells lacking Ras2 grew significantly slower than the wild-type (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), consistent with a substantial reduction in PKA activity. However, deleting <italic>TSA1</italic> in these cells (<italic>ras2Δtsa1Δ</italic>) rescued their slow growth to a rate indistinguishable from that of <italic>tsa1Δ</italic> cells (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), again pointing to an antagonistic effect of Tsa1 on the Ras-PKA pathway, also suggesting that Tsa1 affects the pathway downstream of Ras2. Similarly, overexpressing Ira2, a Ras-GTPase activating protein (RasGAP) that decreases PKA activation by switching RAS-GTP to its inactive GDP form, both slowed down growth to approximately half the rate of control cells (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) and increased expression of Msn2/4-target genes that are under PKA repression (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Deleting <italic>TSA1</italic> in this strain restored both phenotypes (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>), similar to the effect of Ras-overactivation (<italic>RAS2G19V</italic> allele, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>) or Pde2 deficiency (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Importantly, rescue of the slow growth of Ira2-overproducing cells by Tsa1 deletion was lost when <italic>PDE2</italic> was also overexpressed in these cells, also indicating that the rescue is due to increased PKA activity (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The Tsa1 catalytic cysteines affect protein kinase A dependent proliferation downstream of cAMP but not downstream of the catalytic subunits.</title><p>(<bold>A</bold>) Growth of cells lacking Ras2, Tsa1 or both (n = 3, error bars indicate SD). (<bold>B–C</bold>) Growth of cells overexpressing <italic>IRA2</italic> in the indicated mutants of the Tsa1 catalytic cycle or the PKA signaling pathway on solid (<bold>B</bold>) or in liquid medium (<bold>C</bold>), n = 3–15). (<bold>D</bold>) Expression of the PKA repressed <italic>CTT1</italic> or <italic>HSP12</italic> genes in the indicated mutants in the Tsa1 catalytic cycle overexpressing <italic>IRA2</italic> (mc-<italic>IRA2</italic>) or not (instead expressing the vector, control, n = 3 ± SD) sampled during mid-exponential growth. (<bold>E</bold>) Growth of Tsa1-proficient or deficient (<italic>tsa1Δ</italic>) cells overexpressing <italic>IRA2</italic> (mc-<italic>IRA2</italic>) or <italic>PDE2</italic> (mc-<italic>PDE2</italic>), both or the corresponding vector control plasmids (control) in liquid medium (n = 3 ± SD). (<bold>F</bold>) Spore germination in cells deficient in Ras1, Ras2, Tsa1 or combinations thereof. Spore germination was estimated in 32 tetrads where genotypes could be assigned to all spores (128 in total, 8–23 spores per genotype). (<bold>G</bold>) Total time of nuclear Msn2 localization in the indicated mutant strains for 60 min following the addition of 0.3 mM H<sub>2</sub>O<sub>2</sub> (n = 46–82). (<bold>H–I</bold>) Ras-GTP (<bold>H</bold>) or cAMP (<bold>I</bold>) levels in the wild-type or the indicated mutant strains overexpressing <italic>IRA2</italic> (mc-<italic>IRA2</italic>) or not (expressing the vector control, control, n = 3). (<bold>J</bold>) Phosphorylation of the ectopic AKAR4 PKA site upon H<sub>2</sub>O<sub>2</sub> addition (0.4 mM) in wt, <italic>tsa1Δ</italic> and <italic>trx1Δtrx2Δ</italic> cells. (n = 85, 71 and 32, respectively). Error bars indicate SD.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig2-v3.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Tsa1 and the cytosolic thioredoxins Trx1 and Trx2 impact on PKA related growth signaling but lack of Tsa1 cannot overcome the requirement for a PKA catalytic subunit for spore viability.</title><p>(<bold>A-B</bold>) Growth of cells expressing the oncogenic <italic>RAS2G19V</italic> allele, overexpressing <italic>IRA2</italic> (mc-<italic>IRA2</italic>) or both. (<bold>C</bold>) Spore viability in mutants segregating in a <italic>tsa1Δ</italic> x <italic>tpk1Δtpk2Δtpk3Δ</italic> mutant cross. The <italic>tpk1Δ</italic>tpk2D<italic>Δ</italic>tpk3<italic>Δ</italic> mutant was kept alive by a Tpk1-expressing plasmid (pRS313-<italic>TPK1</italic>). Spore viability was estimated in 43 tetrads where genotypes could be assigned to all spores (172 spores in total and in 8-15 spores per genotype). (<bold>D</bold>) Expression of PKA repressed Msn2/4 targets (<xref ref-type="bibr" rid="bib30">Hasan et al., 2002</xref>; <xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>) in wild-type, <italic>tsa1Δ</italic> or <italic>trx1Δ</italic>trx2<italic>Δ</italic> cells deficient in <italic>RAS2</italic> (<italic>ras2Δ</italic>) or not (<italic>RAS2</italic>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig2-figsupp1-v3.tif"/></fig></fig-group><p>Strains lacking both <italic>RAS</italic> alleles (<italic>ras1Δras2Δ</italic>) are not viable due to inactivation of PKA. This inability to germinate can be rescued by genetic interventions that restore PKA activity downstream of Ras, i.e. the inactivation of Pde2 or of the PKA negative regulatory subunit Bcy1 (<xref ref-type="bibr" rid="bib24">Garrett and Broach, 1989</xref>; <xref ref-type="bibr" rid="bib74">Toda et al., 1985</xref>; <xref ref-type="bibr" rid="bib77">Wilson and Tatchell, 1988</xref>), or of Yak1, which acts downstream of PKA. Loss of the PKA-repressed ‘general stress’ transcription factor Msn2 alone or of both Msn2 and its homologue Msn4, can also partially overcome the growth impairment of the partial loss of active Ras (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) and the requirement for a PKA catalytic subunit-encoding (<italic>TPK</italic>)-gene for viability (<xref ref-type="bibr" rid="bib69">Smith, 1998</xref>). As the above data indicate that Tsa1 represses PKA activity, we tested whether its loss could similarly rescue the inability of <italic>ras1Δras2Δ</italic> to germinate by sporulating heterozygous <italic>ras1Δ</italic>/<italic>RAS1</italic>, <italic>ras2Δ</italic>/<italic>RAS2</italic> and <italic>tsa1Δ</italic>/<italic>TSA1</italic> diploid cells. However, no cells lacking both Ras1 and Ras2 were viable irrespective of the presence or absence of Tsa1 (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). Similarly, we did not obtain viable <italic>tsa1Δ tpk1Δ tpk2Δ tpk3Δ</italic> spores in a cross between haploid <italic>tsa1Δ</italic> and <italic>tpk1Δ tpk2Δ tpk3Δ</italic> strains unless a centromeric <italic>TPK1</italic> plasmid was also present (in 6 out of 6 viable spores with the genomic <italic>tsa1Δ tpk1Δ tpk2Δ tpk3Δ</italic> genotype (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). These data suggest that the repression exerted by Tsa1 on the Ras-PKA pathway requires the presence of PKA, and thus that the latter may be the target of repression.</p><p>To further ascertain at which level Tsa1 interferes with Ras-cAMP-PKA activity, we overproduced the PKA negative regulatory subunit (mc-<italic>BCY1</italic>), which by inactivating PKA releases repression of Msn2, and dramatically increases the latter’s response to H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib6">Bodvard et al., 2017</xref>; <xref ref-type="fig" rid="fig2">Figure 2G</xref>). However, mc-<italic>BCY1</italic> had no effect in Tsa1-deficient cells (<xref ref-type="fig" rid="fig2">Figure 2G</xref>), suggesting that Tsa1 inhibits the Ras-cAMP-PKA pathway at the level of the PKA enzyme. We also measured the levels of the pathway signaling intermediates, Ras-GTP and cAMP, in cells overproducing Ira2 in the presence and absence of Tsa1. As expected, overexpression of <italic>IRA2</italic> dramatically reduced the levels of active Ras (Ras-GTP) and this reduction was largely maintained in <italic>pde2Δ</italic> cells (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), in which PKA signaling is increased downstream of Ras. Similarly, Tsa1-deficient cells overproducing Ira2 exhibited very low Ras-GTP levels (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). In addition, cAMP levels were not affected in Tsa1-deficient cells (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). Altogether, these data indicate that repression of the Ras-cAMP-PKA pathway by Tsa1 is needed both during aging and normal growth, and that this repressive effect is exerted at the level of PKA. Lastly, to directly monitor the impact of Tsa1 on PKA activity, we used a PKA sensor in which the phosphorylation state of the ectopic PKA site LLRAT*-LVD in the mammalian FHA1 phospho-amino acid domain is evaluated via FRET (<xref ref-type="bibr" rid="bib53">Molin et al., 2020</xref>). PKA repression upon H<sub>2</sub>O<sub>2</sub> addition was readily visible in wild-type cells using this sensor, whereas cells lacking Tsa1 hardly repressed PKA at all (<xref ref-type="fig" rid="fig2">Figure 2J</xref>).</p><p>Altogether, these data indicate that repression of the Ras-cAMP-PKA pathway by Tsa1 is exerted at the level of PKA, and occurs during aging, in the cell response to H<sub>2</sub>O<sub>2</sub> and during normal growth.</p></sec><sec id="s2-3"><title>Tsa1 catalytic cysteines control H<sub>2</sub>O<sub>2</sub> resistance by repressing PKA</title><p>Prxs can function as H<sub>2</sub>O<sub>2</sub> scavengers, as receptors of H<sub>2</sub>O<sub>2</sub> signaling relays, or as chaperones. The first two functions require Prx-two catalytic Cys residues C<sub>P</sub> and C<sub>R</sub> and electrons from thioredoxin, whereas the third one only relies on the sulfinylation of C<sub>P</sub>. To sort out which of these three Prx biochemical functions is involved in PKA repression, we examined the effect of mutating C<sub>P</sub> and C<sub>R</sub> or of preventing enzyme sulfinylation on Tsa1-mediated repression. The lifespans of <italic>tsa1C48S</italic> and <italic>tsa1C171S</italic> mutants suffered a lifespan as short as cells lacking Tsa1 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Similarly, both the slow growth and the constitutive expression of the PKA-repressed genes <italic>CTT1</italic> and <italic>HSP12</italic> resulting from Ira2 overproduction were lost in the <italic>tsa1C48S</italic> and <italic>tsa1C171S</italic> mutants (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>). In contrast, cells expressing a truncated form of Tsa1 lacking the C-terminal YF motif (<italic>tsa1ΔYF</italic>), an enzyme form almost totally resilient to sulfinylation (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>), were indistinguishable from wild-type with regards to their lifespan (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), slow growth and Ira2 overexpression-dependent, constitutive Msn2-target expression (<xref ref-type="fig" rid="fig2">Figure 2B–D</xref>), thus excluding an involvement of the Tsa1 chaperone function in PKA repression.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Tsa1 catalytic cysteines slow down aging and increase H<sub>2</sub>O<sub>2</sub>-resistance via inhibiting protein kinase A.</title><p>(<bold>A</bold>) Life spans of wild-type or the indicated genomic <italic>tsa1</italic> mutant strains. In brackets median life-spans and n. (<bold>B</bold>) Spot-test assay of growth in the presence and absence of 1.5 mM H<sub>2</sub>O<sub>2</sub> in YPD plates. (<bold>C</bold>) Quantification of H<sub>2</sub>O<sub>2</sub> resistance in (<bold>B</bold>) (n = 3). (<bold>D</bold>) H<sub>2</sub>O<sub>2</sub> resistance (1.5 mM H<sub>2</sub>O<sub>2</sub>, YPD medium) in the indicated mutants (n = 3). (<bold>E</bold>) H<sub>2</sub>O<sub>2</sub> resistance in cells overexpressing <italic>IRA2</italic> (mc-<italic>IRA2</italic> <bold>+</bold>) or vector control (<bold>-</bold>) 0.4 mM H<sub>2</sub>O<sub>2</sub>, SD medium (n = 3). (<bold>F</bold>) Culture medium H<sub>2</sub>O<sub>2</sub> removal assay of wt (black) and <italic>tsa1Δ</italic> cells (blue) to which 200 μM was added. Inset shows average scavenging rates for cultures upon the addition of 400 μM (n = 3). Error bars indicate SD. (<bold>G</bold>) Average HyPer3 (red) or HyPer3 C199S (black) fluorescence ratio (500 nm/420 nm) in young or aged wild-type or <italic>tsa1Δ</italic> cells +/- 400 μM H<sub>2</sub>O<sub>2</sub> for 10 min. Cells of about 10–12 generations of replicative age (aged) or young control cells (young) were assayed. Error bars indicate SEM (n = 231, 170, 319, 236 and 202, respectively). (<bold>H</bold>) Average HyPer3 (red) or HyPer3 C199S (black) fluorescence ratio (500 nm/420 nm) in young or aged wild-type (YMM130) and o/e <italic>TSA1</italic> cells as in (<bold>G</bold>) Error bars indicate SEM (n = 404, 579, 190 and 204, respectively).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig3-v3.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Reduced Ras activity can overcome H<sub>2</sub>O<sub>2</sub> sensitivity of cells lacking Tsa1 but not that of cell lacking the cytosolic thioredoxins Trx1 and Trx2.</title><p>(<bold>A</bold>) H<sub>2</sub>O<sub>2</sub> resistance in the indicated mutant strains strains grown to mid exponential phase (OD 0.3) and spotted onto plates with or without the indicated amounts of H<sub>2</sub>O<sub>2</sub>. (<bold>B</bold>) H<sub>2</sub>O<sub>2</sub> resistance in the indicated mutant strains strains grown to early (OD0.01) and mid exponential phase (OD0.5) and spotted onto plates with or without the indicated amounts of H<sub>2</sub>O<sub>2</sub>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig3-figsupp1-v3.tif"/></fig></fig-group><p>Next, to differentiate between the scavenging and signaling functions of Tsa1, we first probed the H<sub>2</sub>O<sub>2</sub> sensitivity phenotype of cells lacking Tsa1. The <italic>tsa1</italic>Δ was sensitive to H<sub>2</sub>O<sub>2</sub>, as monitored by growth on plates containing H<sub>2</sub>O<sub>2</sub>, and strikingly, deletion of <italic>RAS2</italic> or the overproduction of Ira2 totally rescued this phenotype (<xref ref-type="fig" rid="fig3">Figure 3B–C</xref>). Deletion of <italic>PDE2</italic> in these cells (<italic>ras2Δtsa1Δpde2Δ</italic> or <italic>pde2Δtsa1Δ</italic> mc<italic>−IRA2</italic>) restored the H<sub>2</sub>O<sub>2</sub> sensitivity of <italic>tsa1</italic>Δ (<xref ref-type="fig" rid="fig3">Figure 3E</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>), further indicating that the <italic>tsa1</italic>Δ Η<sub>2</sub>O<sub>2</sub> phenotype is linked to overactive PKA, and not to the loss of Tsa1 scavenging function. Similarly, mild overexpression of <italic>TSA1</italic> conferred an increased tolerance to H<sub>2</sub>O<sub>2</sub>, which was lost upon deletion of <italic>PDE2</italic> (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). As another indication of Tsa1 scavenging function dispensability, the decay rate of H<sub>2</sub>O<sub>2</sub> in the medium of <italic>tsa1</italic>Δ cells after adding a bolus dose was similar to the rate observed in a wild-type cell suspension (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). In addition, H<sub>2</sub>O<sub>2</sub> levels measured using the genetically encoded H<sub>2</sub>O<sub>2</sub> sensor HyPer3 (<xref ref-type="bibr" rid="bib4">Bilan et al., 2013</xref>) were modestly, but significantly increased in old wild-type (10–12 generations), relative to young cells (<xref ref-type="fig" rid="fig3">Figure 3G</xref>). Tsa1-deficient cells however, exhibited a similar or even lower increase in the H<sub>2</sub>O<sub>2</sub> fluorescence ratio with age, relative to wild-type, and in cells expressing an extra copy of the <italic>TSA1</italic> gene, H<sub>2</sub>O<sub>2</sub> increased to a similar or even higher levels in aged cells (<xref ref-type="fig" rid="fig3">Figure 3H</xref>).</p><p>We also examined the role of the thioredoxin pathway in PKA repression, which although required for both Tsa1 signaling and scavenging functions, should be more important for the latter. Deletion of <italic>TRX1</italic> and <italic>TRX2</italic> partly rescued the slow growth of <italic>IRA2-</italic>overexpressing cells (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>), and suppressed the increased constitutive expression of the PKA-repressed Msn2/4 target genes resulting from Ras2 deletion (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>), the latter even more so than did the deletion of <italic>TSA1.</italic> However, although H<sub>2</sub>O<sub>2</sub> sensitive, this <italic>trx1Δtrx2Δ</italic> strain H<sub>2</sub>O<sub>2</sub> phenotype could neither be rescued by deletion of <italic>RAS2</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>) nor by the overproduction of Ira2 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). In addition, PKA was still moderately repressed in <italic>trx1Δtrx2Δ</italic> in response to H<sub>2</sub>O<sub>2</sub>, as measured with the FRET PKA phosphorylation sensor (<xref ref-type="fig" rid="fig2">Figure 2J</xref>). Thioredoxins are thus only partially required to repress the phosphorylation of an ectopic PKA target site upon H<sub>2</sub>O<sub>2</sub> addition, or may govern signaling through another pathway that synergizes with PKA in some PKA output functions. Nevertheless, that the Tsa1 catalytic Cys residues are critical to restrain PKA activity, but not the thioredoxins further exclude the Tsa1 scavenging function per se.</p></sec><sec id="s2-4"><title>Tpk1 is sulfenylated upon H<sub>2</sub>O<sub>2</sub> addition and glutathionylated on the conserved Cys243</title><p>If indeed Tsa1 inhibits PKA, we asked by which mechanism this happens. We detected in myc-Tsa1 immunoprecipitates from unstressed cells a weak, but significant amount of Tpk1, the amount of which increased dramatically following H<sub>2</sub>O<sub>2</sub> addition (0.4 mM, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Moreover, immunoprecipitating Tpk1-HB brought down a significant amount of Tsa1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). We next asked whether PKA underwent thiol-redox modifications. Non-reducing electrophoresis did not identify any migration changes compatible with the presence of a disulfide in neither of Tpk1 nor Bcy1 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–C</xref>). Similarly, kinetic-based trapping using <italic>tsa1</italic>- and <italic>trx2</italic>-resolving cysteine mutants (<italic>tsa1C171S</italic> and <italic>trx2C34S</italic>) neither altered Bcy1 nor Tpk1 migration (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B–D</xref>). We thus performed a mass spectrometry (MS) analysis using affinity-purified His-biotin-tagged Tpk1 (Tpk1-HB) (<xref ref-type="bibr" rid="bib73">Tagwerker et al., 2006</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1A</xref>). We first performed shot-gun MS and open search analysis to determine the most abundant Tpk1 PTMs of its two Cys residues, Cys195 and Cys243, followed by a targeted label-free quantification approach on a selected set of peptides using parallel reaction monitoring (PRM). A significant proportion of Cys195 was present as an adduct with glutathione (GSH) in unstressed cells (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>), and levels of all three peptides bearing this modification decreased by 6 and 11-fold upon cell exposure to 0.4 mM and 0.8 mM H<sub>2</sub>O<sub>2</sub>, respectively (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1F</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1C-D</xref>). A significant fraction of Tpk1 Cys243 was also glutathionylated, even in unstressed cells, and in this peptide, Thr241 was phosphorylated (<xref ref-type="fig" rid="fig4">Figure 4B–C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G–H</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1B</xref>). We also detected variants of this peptide bearing other cysteine modifications (i.e. methyl thiolation, sulfinylation and unknown modifications, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>). Importantly, Thr241 phosphorylation decreased upon exposure to H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>), as did Cys243 glutathionylation (2.5-fold), when it occurred on the phosphorylated peptide (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). However, the Cys243 glutathionylated Thr241 dephosphorylated peptide increased by 1.4 fold. Confirming MS results, Tpk1 was glutathionylated in unstressed cells, when monitored by anti-glutathione immunoblot of immunoprecipitated Tpk1-HB (<xref ref-type="fig" rid="fig4">Figure 4E–F</xref>), and this signal decreased upon exposure to H<sub>2</sub>O<sub>2</sub>. Further, in <italic>tsa1Δ</italic> cells, the glutathionylation signal was more intense, and did not decrease, but rather increased upon H<sub>2</sub>O<sub>2</sub> exposure. We also used DYn-2, a cell-permeable cysteine sulfenic acid (-SOH) probe amenable to click chemistry (<xref ref-type="bibr" rid="bib79">Yang et al., 2015</xref>) as another approach to probe Tpk1 oxidative modifications. In wild-type unstressed cells, Tpk1 displayed a weak DYn-2 signal, the intensity of which significantly increased upon H<sub>2</sub>O<sub>2</sub> addition, whereas in <italic>tsa1Δ</italic> cells this signal was much less intense, both prior to and after exposure to H<sub>2</sub>O<sub>2</sub> (0.4 mM, <xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1I</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Tsa1 interacts with the PKA catalytic subunit Tpk1 and stimulates Tpk1 cysteine sulfenylation by H<sub>2</sub>O<sub>2</sub>.</title><p>Tpk1 is glutathionylated at a conserved cysteine. (<bold>A</bold>) Tpk1 interacts with myc-Tsa1 in a coimmunoprecipitation assay and in a manner strongly stimulated by H<sub>2</sub>O<sub>2</sub>. (<bold>B</bold>) MS-MS spectrum showing the matching b-ion (blue) and y-ion (red) series following fragmentation of the Thr241 phosphorylated and C243 glutathionylated peptide encompassing amino acid residues Y239-K261 in Tpk1. T-P = phospho threonine, C-SSG = glutathionylated cysteine. (<bold>C</bold>) PRM-based quantification of the indicated Thr241 and Cys243 containing Y239-K261 peptides in Tpk1, in the absence or presence of the indicated amount of H<sub>2</sub>O<sub>2</sub>, respectively (n = 3). Error bars indicate SD. (<bold>D</bold>) DYn-2 assay showing Tpk1 cysteine sulfenylation in the presence and absence of <italic>TSA1</italic> and +/- 0.5 mM H<sub>2</sub>O<sub>2</sub> for 5 min. Tpk1-HB was immunoprecipitated from <italic>tpk2Δtpk3Δ</italic> (<italic>TSA1</italic>) and <italic>tpk2Δtpk3Δtsa1Δ</italic> (<italic>tsa1Δ</italic>) cells and analyzed in gel for cyanine5 fluorescence. (<bold>E–F</bold>) Glutathionylation of Tpk1-HB in strains in (<bold>D</bold>) as assayed by anti-glutathione immunoblot of immunoprecipitated Tpk1-HB in the absence of or 10 min following the addition of 0.4 mM H<sub>2</sub>O<sub>2</sub>. Extracts were separated under non-reducing conditions (n = 3).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig4-v3.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Tsa1 interacts with the PKA catalytic subunits Tpk1, controls Tpk1 cysteine sulfenylation independent on disulphide formation and a significant proportion of Tpk1 cysteines are glutathionylated under basal conditions.</title><p>(<bold>A</bold>) Tsa1 interacts with Tpk1 in a Ni<sup>2+</sup>-sepharose coimmunoprecipitation assay (Tpk1-HB <italic>tpk2Δtpk3Δ</italic> strain or <italic>tpk1Δtpk3Δ</italic> strain used as a negative control). An arrow indicates the Tpk1 specific band, whereas * indicates an unspecific band. (<bold>B-C</bold>) Bcy1 (B) or Tpk1 (C) redox immunoblots of protein extracts isolated from the indicated thioredoxin mutant strains in the absence of stress (H<sub>2</sub>O<sub>2</sub> -) or following the addition of 0.4 mM H<sub>2</sub>O<sub>2</sub> for 20 min (H<sub>2</sub>O<sub>2</sub> +). NR = non-reducing R = reducing CS = <italic>trx2C34S</italic> SS = <italic>trx2C31SC34S</italic>. (<bold>D</bold>) Tpk1 redox immunoblots of protein extracts isolated from the indicated myc-<italic>tsa1</italic> mutant strains in the absence of stress (Time in H<sub>2</sub>O<sub>2</sub> = 0) or 10 or 120 min following the addition of 0.4 mM H<sub>2</sub>O<sub>2</sub>. (<bold>E, G</bold>) Mass-shifts in peptides covering the indicated Tpk1 cysteines detected using unbiased open search approaches. Tpk1-Cys195 denotes the F189-K204 peptide whereas Tpk1-Cys243 the Y239-K261 peptide. (<bold>F</bold>) PRM-based quantification of the indicated C195 containing Tpk1 peptides (n=3). Error bars indicate SD. (<bold>H</bold>) PRM-based quantification of the Thr241 phosphorylated and Cys243 sulfinic acid containing Y239-K261 peptide in Tpk1 (n=3). Error bars indicate SD. (<bold>I</bold>) DYn-2 sulfenylation assay depicting oxidation of Tpk1 following the addition of 0.5 mM of H<sub>2</sub>O<sub>2</sub> for 5 min or not in the presence and absence of <italic>TSA1</italic>. Tpk1-HB was immunoprecipitated from <italic>tpk2Δtpk3Δ</italic> (<italic>TSA1</italic>) and <italic>tpk2Δtpk3Δ tpk2Δtsa1Δ</italic> (<italic>tsa1</italic>Δ) cells and analyzed in gel for cyanine5 fluorescence. Arrows indicate Tpk1. Coomassie staining was used to assess total protein used in the assay.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig4-figsupp1-v3.tif"/></fig></fig-group><p>The two Tpk1 Cys residues thus undergo complex redox changes comprising glutathionylation and sulfenylation as dominant and biologically relevant modifications. These changes occur independently, the former present in unstressed cells, decreasing upon H<sub>2</sub>O<sub>2</sub> exposure, and the latter strongly induced by H<sub>2</sub>O<sub>2</sub>, both dependent upon Tsa1. The fact that the increased sulfenylation of Tpk1 upon H<sub>2</sub>O<sub>2</sub> addition correlates with Thr241 dephosphorylation led us to probe the importance of all three residues in Tpk1 function by Ala substitution. These substitutions altered neither protein levels nor the ability of cells to grow (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–D</xref>). Interestingly, <italic>tpk1C243A</italic>, but not <italic>tpk1C195A</italic> rendered cells hyper-sensitive to H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>), which was not improved by mild overexpression of <italic>TSA1</italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). In contrast, the <italic>tpk1T241A</italic> mutant significantly increased H<sub>2</sub>O<sub>2</sub> resistance both in wild-type (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) and in <italic>tsa1</italic>Δ cells (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). A docking experiment performed on a Tpk1 3D structural homology model based on the mouse enzyme structure (<xref ref-type="fig" rid="fig5">Figure 5D–E</xref>), showed that introducing a glutathione moiety at Cys243 stabilized Thr241 in the dephosphorylated state by direct hydrogen bonding (<xref ref-type="fig" rid="fig5">Figure 5F–H</xref>). When Thr241 was phosphorylated, the kinase activation loop was now stabilized through hydrogen bonds to Arg209 and Lys233 (<xref ref-type="fig" rid="fig5">Figure 5F–G</xref>), and in this setting, glutathione at Cys243 adopted a different position, now extending towards the ATP-binding pocket (<xref ref-type="fig" rid="fig5">Figure 5I</xref>). Subsitution of Cys243 to the less bulky cysteine sulfenic/sulfinic acid mimetic aspartate (<italic>tpk1C243D</italic>), or modification by methylthiolation (S-CH<sub>3</sub>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1E</xref>) had, however, little effect on the molecular dynamics of Tpk1 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1F–G</xref>). In summary, Cys243 glutathionylation might inhibit PKA by interfering both with Thr241 phosphorylation and with the ATP-binding pocket dynamics, when occurring together with phosphorylated Thr241, which would not fit the observed decreased glutathionylation of Tpk1 seen upon H<sub>2</sub>O<sub>2</sub> addition. Alternatively, the Cys243 sulfenic acid may react further as previously speculated for the redox modulation of the ER kinase IRE-1 (<xref ref-type="bibr" rid="bib34">Hourihan et al., 2016</xref>) and our 3D data suggest that a more bulky modification may be the driving event in PKA repression. Taken together, these data support the presence of a Tsa1 thiol-based redox mechanism in PKA repression.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Tpk1 Cys243 redox-modification and Tsa1 inhibits PKA activity by dephosphorylating and destabilizing the activation loop.</title><p>(<bold>A–B</bold>) H<sub>2</sub>O<sub>2</sub> resistance of the wild-type vector control (<bold>A</bold>, pRS313 or <bold>B</bold>, pRS403) or the indicated <italic>tsa1</italic>- or <italic>tpk</italic>-mutant strains in SD medium, 0.6 mM H<sub>2</sub>O<sub>2</sub>. Strains in (<bold>B</bold>) carry pRS316-<italic>TPK1</italic> or pRS316-<italic>tpk1C243A</italic> as the only PKA catalytic subunit peroxiredoxin Tsa1 slows down (genomic <italic>tpk1Δtpk2Δtpk3Δ</italic> deletions, n = 3). (<bold>C</bold>) H<sub>2</sub>O<sub>2</sub> resistance of <italic>tpk1Δtpk2Δtpk3Δ</italic> and <italic>tpk1Δtpk2Δtpk3Δtsa1Δ</italic> cells transformed with pRS313-<italic>TPK1</italic> or pRS313-<italic>tpk1T241A</italic> as indicated in SD medium 0.6 mM H<sub>2</sub>O<sub>2</sub> (n = 3). (<bold>D–E</bold>) Structural homology model of yeast Tpk1 (<bold>D</bold>) based on the structure of mouse type II PKA holoenzyme (<bold>E</bold>) [PDB ID 3TNP, (<xref ref-type="bibr" rid="bib81">Zhang et al., 2012</xref>). (<bold>F–I</bold>) Amino acids in the activation loop (in red) of Tpk1 in the Thr241 phosphorylated Cys243 non-modified (<bold>F</bold>), Thr241 non-phosphorylated Cys243 non-modified (<bold>G</bold>), Thr241 non-modified Cys243 glutathionylated (<bold>H</bold>) and Thr241 phosphorylated Cys243 glutathionylated (<bold>I</bold>) states in the Tpk1 structural homology model. The backbones are colored in light blue, carbon atoms in yellow, nitrogen atoms in blue, oxygen atoms in red and phosphor atoms in scarlet. The distance between Lys233 and phosphorylated Thr241 is 9.55 Å (<bold>F</bold>) whereas Lys233 and non-phosphorylated Thr241 reside 10.88 Å apart (<bold>G</bold>). (<bold>J</bold>) Overview of mechanisms by which glucose and H<sub>2</sub>O<sub>2</sub> control PKA activity. In blue activators and in red inhibitors. See also <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig5-v3.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Substitution of Cys195, Thr241 and Cys243 by alanine in the yeast.</title><p>PKA catalytic subunit Tpk1 neither affects viability nor growth, whereas in silico simulation suggest that glutathionylation, but not sulfenylation, of Tpk1Cys243 significantly impacts on Tpk1 structure.</p><p>(<bold>A</bold>) Growth of <italic>tpk1Δtpk2Δtpk3Δ</italic> cells transformed with the vector (vector) or the indicated pRS313-<italic>TPK1</italic> plasmids and pRS316-<italic>TPK1</italic> (p<italic>TPK1</italic>-<italic>URA3</italic>) on solid synthetic defined (-HIS, 5-FOA) medium to counterselect p<italic>TPK1</italic>-<italic>URA3</italic>. (<bold>B</bold>) Growth of the strains in (<bold>A</bold>) on solid synthetic defined selective (-HIS, URA) medium. Cells in A) and B) were left to grow for 3 days before photographed. (<bold>C</bold>) Doubling time of the indicated <italic>tpk</italic>-mutant strains in synthetic defined -HIS medium. (<bold>D</bold>) Tpk1 levels are not significantly altered in Tpk1 substitution mutants neither with nor without H<sub>2</sub>O<sub>2</sub> (0.4 mM. 10 min). Pgk1 levels were used to indicate protein loading. (<bold>E</bold>) H<sub>2</sub>O<sub>2</sub> resistance of <italic>TPK1 tpk2Δ tpk3Δ</italic> and <italic>tpk1C195A tpk2Δ tpk3Δ</italic>-mutants as indicated. (<bold>F</bold>) Alignment of cysteine (green), aspartate (blue), methylthiolated (pink) or glutathionylated cysteine (grey) in position 243 in the Tpk1 homology model. (<bold>G</bold>) Root-mean-square deviation of the C-alpha distances in C243-SH (orange), Cys243Asp (blue), Cys243 methylthiolated (yellow) and C243 glutathionylated enzyme (Cys243-SSG, grey) upon molecular dynamic simulation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig5-figsupp1-v3.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Caloric restriction is established as a measure that extends the lifespan of organisms from yeast to primates and this effect occurs by reduced nutrient and/or growth signaling through the insulin/IGF-1, TOR and protein kinase A pathways. However, which effectors/processes downstream of these pathways are regulating the rate of aging is still a matter of controversy. As nutrient signaling coordinates many different cellular processes, the exact identity of the accountable process may differ between organisms and/or CR protocols (<xref ref-type="bibr" rid="bib42">Lamming and Anderson, 2014</xref>). The fact that several of the target processes proposed, as for instance vacuolar pH control and protein homeostasis, reciprocally feed-back control nutrient signaling (<xref ref-type="bibr" rid="bib54">Molin and Demir, 2014</xref>; <xref ref-type="bibr" rid="bib80">Yao et al., 2015</xref>; <xref ref-type="bibr" rid="bib82">Zhang et al., 2013</xref>) has caused further obscured the designation of mechanisms important in slowing down aging. A novel integrative model of aging, however, posits that different pathways and/or organelles are intricately interconnected into so called integrons (<xref ref-type="bibr" rid="bib18">Dillin et al., 2014</xref>), the interconnectivity of which eventually causes a progressive decline of all systems through sequential collapse of homeostasis, when individual subsystems fail.</p><p>Peroxiredoxins have emerged as regulators of aging stimulating longevity in organisms from yeast to worms, flies and mice (<xref ref-type="bibr" rid="bib14">De Haes et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>; <xref ref-type="bibr" rid="bib43">Lee et al., 2009</xref>; <xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>; <xref ref-type="bibr" rid="bib58">Oláhová and Veal, 2015</xref>). We previously showed that the yeast peroxiredoxin Tsa1 is crucial for molecular chaperones to bind to aggregates forming in aged yeast cells (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>), thus connecting peroxiredoxins to an aging factor conserved in many organisms. We linked this role to the sulfinylation of the enzyme primary catalytic cysteine and protein decamerization, thus providing a demonstration of the in vivo occurrence of this in vitro-described peroxiredoxin chaperone function (<xref ref-type="bibr" rid="bib38">Jang et al., 2004</xref>; <xref ref-type="bibr" rid="bib56">Noichri et al., 2015</xref>). We also previously observed that H<sub>2</sub>O<sub>2</sub> resistance in CR cells requires both catalytic cysteines (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>), and metformin, which extends lifespan in worms, causes the accumulation of disulfide-linked Prdx-2 in worms. These data indicated that handling protein aggregates might not be the only means by which peroxiredoxins regulate aging. Data reported in this study now demonstrate a key role of both cysteines of Tsa1 in slowing down aging, also correlating peroxiredoxin-stimulated longevity and hydrogen peroxide resistance. Surprisingly, the requirement for peroxiredoxin-catalytic cysteines in both aging and H<sub>2</sub>O<sub>2</sub> resistance is not linked to H<sub>2</sub>O<sub>2</sub> scavenging, but to the modulation of PKA. Taken together with the Tsa1-dependent increased lifespan in cells grown in the continuous presence of low levels of H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib27">Goulev et al., 2017</xref>), these data demonstrate that at least two of the anti-aging effects of peroxiredoxins originates in H<sub>2</sub>O<sub>2</sub> signaling. Accordingly, what are the phenotypes dependent on the scavenging function of Tsa1, and of peroxiredoxins in general? Compelling arguments for local scavenging by mouse PrdxI that modulate growth factor signaling have been made (<xref ref-type="bibr" rid="bib78">Woo et al., 2010</xref>), but literature too often equate a requirement of peroxiredoxin catalytic cysteines with a role of the enzyme in scavenging. Our data now indicate that peroxiredoxins, when bearing its two catalytic residue, can override conventional second-messenger controlled signaling mechanisms to directly modulate protein kinase A signaling as a function of the level of H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="fig5">Figure 5J</xref>).</p><p>How is this modulation of PKA by Tsa1 occuring? Our data provide evidence for a direct Tsa1-Tpk1 physical interaction, Tsa1-dependent Tpk1 cysteine sulfenylation and deglutathionylation, and a requirement of Cys243 in H<sub>2</sub>O<sub>2</sub> resistance mediated by mild Tsa1 overexpression. Murine type II PKA is inactivated upon in vitro glutathionylation of the homologous Cys residue (C199) (<xref ref-type="bibr" rid="bib36">Humphries et al., 2005</xref>; <xref ref-type="bibr" rid="bib35">Humphries et al., 2002</xref>). In type II rat PKA, the same Cys residue forms a disulfide bond with the regulatory subunit at very low levels of H<sub>2</sub>O<sub>2 </sub>in vitro (1 μM), which decreases PKA activity (<xref ref-type="bibr" rid="bib15">de Piña et al., 2008</xref>), again highlighting the importance of this residue in PKA redox regulation. The PKA regulatory subunit cysteine is however, only conserved in vertebrates, in contrast to the catalytic subunit cysteine, which is conserved in PKA across eukaryotes (<xref ref-type="bibr" rid="bib15">de Piña et al., 2008</xref>). How does PKA then become redox modified? Are glutathionylation and sulfenylation of the PKA catalytic Cys residues, mechanistically linked, and if so which of them occurs first? Peroxiredoxins can oxidize other proteins by virtue of promiscuity, but disulfide bond formation and not sulfenylation is expected to occur in this case (<xref ref-type="bibr" rid="bib72">Stöcker et al., 2018b</xref>). Furthermore, we could not identify a Tpk1-Tsa1 mixed disulfide by kinetic trapping using a Tsa1 mutant lacking its resolving cysteine (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C</xref>). Protein glutathionylation can occur non-enzymatically by condensation with a preformed sulfenate, a mechanism that may explain Tpk1 glutathionylation, but can also be catalyzed by a glutathione-S-transferase (<xref ref-type="bibr" rid="bib83">Zhang et al., 2018</xref>). A pressing issue for the future will thus be to identify the mechanism by which Tpk1 becomes sulfenylated and glutathionylated and how peroxiredoxins, or possibly other redox enzymes assist these modifications.</p><p>The activities of both protein kinase G and A (PKARIα) are also stimulated by H<sub>2</sub>O<sub>2</sub> (<xref ref-type="bibr" rid="bib8">Burgoyne et al., 2007</xref>; <xref ref-type="bibr" rid="bib9">Burgoyne et al., 2015</xref>). In the protein kinase G Iα isoform, a disulfide linking its two subunits forms in rat cells exposed to H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib8">Burgoyne et al., 2007</xref>). Thus this regulation of PKA/PKG by H<sub>2</sub>O<sub>2</sub> involves the same Cys195 conserved cysteine in the catalytic subunit but leads to opposite effects. Similarly, in vitro studies suggest that the energy-sensing kinase AMPK is activated upon glutathionylation (<xref ref-type="bibr" rid="bib40">Klaus et al., 2013</xref>). In worms and mammals, the endoplasmic reticulum (ER) transmembrane kinase Ire-1 is regulated by oxidation of another conserved Cys residue in the activation loop, situated 11 residues upstream of the here described PKA cysteine, at position +two relative to the Mg<sup>2+</sup>-coordinating DFG motif (<xref ref-type="bibr" rid="bib34">Hourihan et al., 2016</xref>). Furthermore, we recently found that another activation loop cysteine, positioned at DFG −1, in the fission yeast MAPKK, Wis1, restrains Wis1 activation by low levels, but not high, levels of H<sub>2</sub>O<sub>2 </sub>(<xref ref-type="bibr" rid="bib68">Sjölander et al., 2020</xref>). These studies, together with the one presented here, pinpoint oxidation of cysteines in kinase activation loops as prevalent means of fine-tuning protein kinase function in response to H<sub>2</sub>O<sub>2</sub>.</p><p>In summary data presented here and in a previous study (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>) point to two different independent mechanisms by which peroxiredoxins counteract aging and age-related disease (<xref ref-type="fig" rid="fig6">Figure 6</xref>). The first one, described here, involves catalytic cycling and inhibition of nutrient-related kinase signaling (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). This mechanism appears critical for yeast to sustain normal longevity and is probably involved also in the ability of CR to slow down aging, since CR stimulates H<sub>2</sub>O<sub>2</sub> resistance in a manner dependent on Tsa1 catalytic cysteines (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>). Along the same lines, metformin-stimulated longevity in worms also seems to involve increased Prdx-2 disulfide bond formation (<xref ref-type="bibr" rid="bib14">De Haes et al., 2014</xref>). The second mechanism is the stimulation of chaperone-dependent protein quality control that counteract protein aggregation (<xref ref-type="fig" rid="fig6">Figure 6C</xref>; <xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>). Tsa1 sulfinylation is necessary to guide the molecular chaperones Hsp70 and Hsp104 to aggregates forming in aged and H<sub>2</sub>O<sub>2</sub>-treated cells. The requirement of both reduced PKA nutrient signaling and normal protein quality control (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>) for mild Tsa1 overproduction to extend lifespan support a requirement of both these mechanisms for enhanced peroxiredoxin levels to extend lifespan (<xref ref-type="fig" rid="fig6">Figure 6C</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Model of the mechanisms by which altered peroxiredoxin levels impacts on aging.</title><p>In the first mechanism peroxiredoxin-dependent redox-signaling impacts in an unconventional manner on the PKA nutrient signaling kinase (this study) and in the other on proteostasis (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>). (<bold>A</bold>) In wild-type cells Tsa1 catalytic cycling maintains longevity by decreasing PKA-dependent nutrient signaling leading to the stimulation of maintenance but at the expense of growth. (<bold>B</bold>) In cells lacking Tsa1, nutrient signaling is aberrantly increased leading to reduced maintenance and increased growth. (<bold>C</bold>) Enforced expression of the peroxiredoxin Tsa1 slows down aging both by repressing nutrient signaling (this study) and by stimulating protein quality control mechanisms to reduce the levels of damaged and aggregated protein (<xref ref-type="bibr" rid="bib29">Hanzén et al., 2016</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-60346-fig6-v3.tif"/></fig><p>Cellular components and/or pathways that assimilate information from different subsystems, such as the above described nutrient signaling pathways, would thus be expected to have a key role as integrating hubs in the aging process. A role of PKA in integrating yeast homeostatic processes is also suggested by a genome-wide identification of genes controlling PKA regulatory-catalytic subunit interaction, and hence PKA activity, which found a striking number of known PKA targets, involved in glycogen accumulation, filamentous growth and amino-acid biosynthesis (<xref ref-type="bibr" rid="bib21">Filteau et al., 2015</xref>). The role of peroxiredoxins of slowing down aging by modulating central nutrient signaling pathways agrees with the integrative model of aging and suggest that also other anti-aging regimens might impact nutrient signaling.</p><p>The incidence of many major age-related diseases, such as cancer, diabetes and neurodegeneration, can be reduced by caloric restriction (<xref ref-type="bibr" rid="bib50">Mattison et al., 2017</xref>), and there is hope that reducing caloric intake or pharmaceutically targeting key molecular mechanisms underlying its beneficial health effects, such as peroxiredoxins, will fuel healthy, disease-free ageing. As peroxiredoxins are conserved in organisms from bacteria to humans and can be targeted pharmaceutically, they constitute promising targets for the development of drugs against age-related disease.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain background (<italic>Escherichia coli</italic>)</td><td valign="top"><italic>E. coli</italic> BL21 strain expressing pGEX2T-1-GST-RBD</td><td valign="top">This paper, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-017-01019-z">10.1038/s41467-017-01019-z</ext-link></td><td valign="top"/><td valign="top">To purify GST-RBD for Ras-GTP assays</td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top">wt control</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2016.05.006">10.1016/j.cell.2016.05.006</ext-link></td><td valign="top">YMM130</td><td valign="top">MAT alpha <italic>his3Δ1::pRS403, leu2Δ0 lys2Δ0 ura3Δ0</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top">o/e <italic>TSA1</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2016.05.006">10.1016/j.cell.2016.05.006</ext-link></td><td valign="top">o/e <italic>TSA1</italic></td><td valign="top">MAT alpha <italic>his3Δ1::pRS403-Myc-TSA1, leu2Δ0 lys2Δ0 ura3Δ0</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>pde2Δ control</italic></td><td valign="top">This paper</td><td valign="top">YMM175</td><td valign="top">MAT <bold>alpha</bold> <italic>his3Δ1::pRS403, leu2Δ0 lys2Δ0 ura3Δ0 pde2Δ::kanMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>pde2Δ</italic> o/e <italic>TSA1</italic></td><td valign="top">This paper</td><td valign="top">YMM176</td><td valign="top">MAT <bold>alpha</bold> <italic>his3Δ1::pRS403-Myc-TSA1, leu2Δ0 lys2Δ0 ura3Δ0 pde2Δ::kanMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top">wt</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/(SICI)1097-0061">10.1002/(SICI)1097-0061</ext-link>(19980130)14:2&lt;115::AID-YEA204&gt;3.0.CO;2–2.</td><td valign="top">BY4742</td><td valign="top">MAT <bold>alpha</bold> <italic>his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tsa1Δ</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.07.027">10.1016/j.molcel.2011.07.027</ext-link></td><td valign="top">YMM114</td><td valign="top">BY4742 <italic>tsa1Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>ras2Δ</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.07.027">10.1016/j.molcel.2011.07.027</ext-link></td><td valign="top">YMM113</td><td valign="top">BY4742 <italic>ras2Δ::kanMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>ras2Δtsa1Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM170</td><td valign="top">BY4742 <italic>ras2Δ::kanMX4 tsa1Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>pde2Δ</italic></td><td valign="top">Research Genetics, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature00935">10.1038/nature00935</ext-link>.</td><td valign="top"><italic>pde2Δ</italic></td><td valign="top">BY4742 <italic>pde2Δ::kanMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>ras2Δpde2Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM171</td><td valign="top">BY4742 <italic>ras2Δ::kanMX4 pde2Δ::hphMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>pde2Δtsa1Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM172</td><td valign="top">BY4742 <italic>pde2Δ::kanMX4 tsa1Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>ras2Δpde2Δtsa1Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM173</td><td valign="top">BY4742 <italic>ras2Δ::kanMX4 pde2Δ::hphMX4 tsa1Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tsa1C48S</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms14791">10.1038/ncomms14791</ext-link></td><td valign="top">YMM145</td><td valign="top">BY4742 <italic>tsa1C48S</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tsa1C171S</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms14791">10.1038/ncomms14791</ext-link></td><td valign="top">YMM146</td><td valign="top">BY4742 <italic>tsa1C171S</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tsa1ΔYF</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms14791">10.1038/ncomms14791</ext-link></td><td valign="top">YMM147</td><td valign="top">BY4742 <italic>tsa1(1-184)</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tsa1C171SΔYF</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms14791">10.1038/ncomms14791</ext-link></td><td valign="top">YMM148</td><td valign="top">BY4742 <italic>tsa1(1-184)C171S</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>trx1Δtrx2Δ</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms14791">10.1038/ncomms14791</ext-link></td><td valign="top">YMM143</td><td valign="top">BY4742 <italic>trx1Δ::hphMX4 trx2Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>msn2Δmsn4Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM174</td><td valign="top">BY4742 <italic>msn2Δ::hphMX4 msn4Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>ras1Δ::hphMX4</italic></td><td valign="top">This paper</td><td valign="top">YMM177</td><td valign="top"><bold>MAT a</bold>, <italic>his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 ras1Δ::hphMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"/><td valign="top">This paper</td><td valign="top">YMM178</td><td valign="top">BY-2n <italic>met15Δ0</italic>/<italic>MET15 lys2Δ0</italic>/<italic>LYS2 tpk1Δ::kanMX4/TPK1 tpk2Δ::natMX4/TPK2 tpk3Δ::hphMX4/TPK3</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk3Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM179</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk3Δ::hphMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk2Δtpk3Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM180</td><td valign="top">BY4742 <italic>tpk2Δ::natMX4 tpk3Δ::hphMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA</italic></td><td valign="top">This paper</td><td valign="top">YMM181</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS316-TPK1</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA vector control</italic></td><td valign="top">This paper</td><td valign="top">YMM182</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313 pTPK1-URA3</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA pTPK1</italic></td><td valign="top">This paper</td><td valign="top">YMM183</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-TPK1 pTPK1-URA3</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA3 ptpk1C243A</italic></td><td valign="top">This paper</td><td valign="top">YMM184</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-tpk1C243A pTPK1-URA3</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA3 ptpk1C243D</italic></td><td valign="top">This paper</td><td valign="top">YMM185</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-tpk1C243D pTPK1-URA3</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA3 ptpk1T241A</italic></td><td valign="top">This paper</td><td valign="top">YMM186</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-tpk1T241A pTPK1-URA3</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1</italic></td><td valign="top">This paper</td><td valign="top">YMM187</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-TPK1</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ ptpk1C243A</italic></td><td valign="top">This paper</td><td valign="top">YMM188</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-tpk1C243A</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ ptpk1C243D</italic></td><td valign="top">This paper</td><td valign="top">YMM189</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-tpk1C243D</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ ptpk1T241A</italic></td><td valign="top">This paper</td><td valign="top">YMM190</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS313-tpk1T241A</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>ras2Δtrx1Δtrx2Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM191</td><td valign="top">BY4742 <italic>ras2Δ::kanMX4 trx1Δ::hphMX4 trx2Δ::natMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tsa1Δ::bleMX4</italic></td><td valign="top">This paper</td><td valign="top">YMM192</td><td valign="top">BY4741 <italic>tsa1Δ::bleMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk2Δtpk3Δtsa1Δ</italic></td><td valign="top">This paper</td><td valign="top">YMM193</td><td valign="top">BY4741 <italic>tpk2Δ::natMX4 tpk3Δ::hphMX4 tsa1Δ::bleMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces</italic> <break/> <italic>cerevisiae</italic>)</td><td valign="top"><italic>TPK1-HBH tpk2Δtpk3Δ</italic></td><td valign="top">This paper</td><td valign="top">WR1832</td><td valign="top">BY4742 <italic>TPK1-HBH</italic>::<italic>TRP1 tpk2Δ::natMX4 tpk3Δ::hphMX4 trp1Δ::kanMX4</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA vector control</italic></td><td valign="top">This paper</td><td valign="top">yCP101</td><td valign="top">MAT <bold>a</bold> <italic>his3Δ1::pRS403, leu2Δ0 lys2Δ0 ura3Δ0 tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS316-TPK1</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ ptpk1C243A-URA vector control</italic></td><td valign="top">This paper</td><td valign="top">yCP102</td><td valign="top">MAT <bold>alpha</bold> <italic>his3Δ1::pRS403, leu2Δ0 lys2Δ0 ura3Δ0 tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS316-tpk1C243A</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ pTPK1-URA</italic> o/e <italic>TSA1</italic></td><td valign="top">This paper</td><td valign="top">yCP103</td><td valign="top">MAT <bold>alpha</bold> <italic>his3Δ1::pRS403-myc-TSA1, leu2Δ0 lys2Δ0 ura3Δ0 tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 pRS316-TPK1</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δ ptpk1C243A-URA</italic> o/e <italic>TSA1</italic></td><td valign="top">This paper</td><td valign="top">yCP104</td><td valign="top">MAT <bold>alpha</bold> <italic>his3Δ1::pRS403-myc-TSA1, leu2Δ0 lys2Δ0 ura3Δ0 tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4</italic> pRS316-<italic>tpk1C243A</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δtsa1Δ pTPK1</italic></td><td valign="top">This paper</td><td valign="top">yCP105</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 tsa1Δ::bleMX4 pRS313-TPK1</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>tpk1Δtpk2Δtpk3Δtsa1Δ ptpk1T241A</italic></td><td valign="top">This paper</td><td valign="top">yCP106</td><td valign="top">BY4742 <italic>tpk1Δ::kanMX4 tpk2Δ::natMX4 tpk3Δ::hphMX4 tsa1Δ::bleMX4 pRS313-tpk1T241A</italic></td></tr><tr><td valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td valign="top"><italic>TPK1-HBH tpk2Δtpk3Δtsa1Δ</italic></td><td valign="top">This paper</td><td valign="top">yCP107</td><td valign="top">BY4742 <italic>TPK1-HBH</italic>::<italic>TRP1 tpk2Δ::natMX4 tpk3Δ::hphMX4 tsa1Δ::bleMX4 trp1Δ::kanMX4 tsa1Δ::bleMX4</italic></td></tr><tr><td valign="top">Antibody</td><td valign="top">(mouse monoclonal) anti-Tpk1</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">Sc-374592, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10990730">AB_10990730</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">(goat polyclonal) anti-Bcy1</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">Sc-6734, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_671758">AB_671758</ext-link></td><td valign="top">(1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">(rabbit) IgG; anti-Protein A</td><td valign="top">Sigma Aldrich</td><td valign="top">I5006, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1163659">AB_1163659</ext-link></td><td valign="top">1 μg/ml</td></tr><tr><td valign="top">Antibody</td><td valign="top">(goat polyclonal) anti-Ras2</td><td valign="top">Santa Cruz Biotechnology</td><td valign="top">Sc-6759, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_672465">AB_672465</ext-link></td><td valign="top">(1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">(mouse monoclonal) anti-Glutathione (D8)</td><td valign="top">Abcam</td><td valign="top">ab19534, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_880243">AB_880243</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">(mouse monoclonal) anti-Pgk1 (22C5D8)</td><td valign="top">Thermo Fisher</td><td valign="top">459250, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2532235">AB_2532235</ext-link></td><td valign="top">(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">(mouse monoclonal) anti-2 Cys Prx (6E5); (anti-Tsa1)</td><td valign="top">Abcam</td><td valign="top">ab16765, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_443456">AB_443456</ext-link></td><td valign="top">(1:1000)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">yEP24</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0378-1119(79)90004-0">10.1016/0378-1119(79)90004-0</ext-link></td><td valign="top"/><td valign="top">yeast 2μ, <italic>URA3</italic> vector plasmid</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pKF56</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mcb.10.8.4303">10.1128/mcb.10.8.4303</ext-link>.</td><td valign="top"/><td valign="top"><italic>IRA2</italic> in yEP24</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS425</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0378-1119(92)90454w">10.1016/0378-1119(92)90454w</ext-link>.</td><td valign="top"/><td valign="top">yeast 2μ, <italic>LEU2</italic> vector plasmid</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">yEP13-<italic>PDE2</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/emboj/cdg314">10.1093/emboj/cdg314</ext-link>.</td><td valign="top"/><td valign="top"><italic>PDE2</italic> in yeast 2μ, <italic>LEU2</italic> plasmid</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">yEPlac195</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/0378-1119(88)90185-0">10.1016/0378-1119(88)90185-0</ext-link>.</td><td valign="top"/><td valign="top">yeast 2μ, <italic>URA3</italic> vector plasmid</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pXP1</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mcb.19.7.4874">10.1128/mcb.19.7.4874</ext-link>.</td><td valign="top"/><td valign="top"><italic>BCY1</italic> in yEPlac195</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS315</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/2659436">2659436</ext-link></td><td valign="top"/><td valign="top">yeast CEN/ARS, <italic>LEU2</italic> empty vector plasmid</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">B561 (pRS315-<italic>RAS2G19V</italic>)</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/mcb.19.10.6775">10.1128/mcb.19.10.6775</ext-link>.</td><td valign="top"/><td valign="top"><italic>RAS2G19V</italic> in pRS315</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pHyPer3C199S (pRS416-<italic>GPD-HyPer3C199S</italic>)</td><td valign="top">This paper, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/cb300625g">10.1021/cb300625g</ext-link></td><td valign="top"/><td valign="top">HyPer3C199S</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS416-<italic>GPD-AKAR4</italic></td><td valign="top"><xref ref-type="bibr" rid="bib53">Molin et al., 2020</xref></td><td valign="top"/><td valign="top">AKAR4 in pRS416-GPD [CEN/ARS, pGPD promotor, <italic>URA3</italic>]</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS316</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/2659436">2659436</ext-link></td><td valign="top"/><td valign="top">yeast CEN/ARS, <italic>URA3</italic> empty vector plasmid</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS316- <italic>myc-TSA1</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature02075">10.1038/nature02075</ext-link>.</td><td valign="top"/><td valign="top">Myc-<italic>TSA1</italic> in pRS316</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS316- <italic>myc-tsa1C48S</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.07.027">10.1016/j.molcel.2011.07.027</ext-link></td><td valign="top"/><td valign="top">Myc-<italic>tsa1C48S</italic> in pRS316</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS316- <italic>myc-tsa1C171S</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.07.027">10.1016/j.molcel.2011.07.027</ext-link></td><td valign="top"/><td valign="top">Myc-<italic>tsa1C171S</italic> in pRS316</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS315-ProtA</td><td valign="top">This paper</td><td valign="top"/><td valign="top">ProteinA in pRS315</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS315-<italic>TRX2-ProteinA</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/ncomms14791">10.1038/ncomms14791</ext-link></td><td valign="top"/><td valign="top"><italic>TRX2-ProtA</italic> in pRS315</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS315-<italic>trx2C34S-ProteinA</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"><italic>trx2C34S-ProtA</italic> in pRS315</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS315-<italic>trx2C31SC34S-ProteinA</italic></td><td valign="top">This paper</td><td valign="top"><italic>trx2C31SC34S-ProtA</italic> in pRS315</td><td valign="top"><italic>trx2C31SC34S-ProtA</italic> in pRS315</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS313</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2659436/">2659436</ext-link></td><td valign="top">yeast CEN/ARS, <italic>HIS3</italic> empty vector</td><td valign="top">yeast CEN/ARS, <italic>HIS3</italic> empty vector</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS313-<italic>TPK1</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M110.200071">10.1074/jbc.M110.200071</ext-link>.</td><td valign="top"><italic>TPK1</italic> in pRS313</td><td valign="top"><italic>TPK1</italic> in pRS313</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS313-<italic>tpk1C243A</italic></td><td valign="top">This paper</td><td valign="top"><italic>tpk1C243A</italic> in pRS313</td><td valign="top"><italic>tpk1C243A</italic> in pRS313</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS313-<italic>tpk1C243D</italic></td><td valign="top">This paper</td><td valign="top"><italic>tpk1C243D</italic> in pRS313</td><td valign="top"><italic>tpk1C243D</italic> in pRS313</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pRS313-<italic>tpk1T241A</italic></td><td valign="top">This paper</td><td valign="top"><italic>tpk1T241A</italic> in pRS313</td><td valign="top"><italic>tpk1T241A</italic> in pRS313</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">p<italic>TPK1-URA3</italic> (pRS316<italic>-TPK1</italic>)</td><td valign="top">Karin Voordeckers</td><td valign="top"><italic>TPK1</italic> in pRS316</td><td valign="top"><italic>TPK1</italic> in pRS316</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">p<italic>tpk1C243A-URA3</italic></td><td valign="top">This paper</td><td valign="top"><italic>tpk1C243A</italic> in pRS316</td><td valign="top"><italic>tpk1C243A</italic> in pRS316</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>ACT1F</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.03.021">10.1016/j.molcel.2011.03.021</ext-link></td><td valign="top">For Q-PCR of <italic>ACT1</italic></td><td valign="top"><named-content content-type="sequence">CTGCCGGTATTGACCAAACT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>ACT1R</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.03.021">10.1016/j.molcel.2011.03.021</ext-link></td><td valign="top">For Q-PCR of <italic>ACT1</italic></td><td valign="top"><named-content content-type="sequence">CGGTGAATTTCCTTTTGCATT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>CTT1F</italic></td><td valign="top">This paper</td><td valign="top">For Q-PCR of <italic>CTT1</italic></td><td valign="top"><named-content content-type="sequence">GCTTCTCAATACTCAAGACCAG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>CTT1R</italic></td><td valign="top">This paper</td><td valign="top">For Q-PCR of <italic>CTT1</italic></td><td valign="top"><named-content content-type="sequence">GCGGCGTATGTAATATCACTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>HSP12F</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.03.021">10.1016/j.molcel.2011.03.021</ext-link></td><td valign="top">For Q-PCR of <italic>HSP12</italic></td><td valign="top"><named-content content-type="sequence">AGGTCGCTGGTAAGGTTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top"><italic>HSP12R</italic></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.molcel.2011.03.021">10.1016/j.molcel.2011.03.021</ext-link></td><td valign="top">For Q-PCR of <italic>HSP12</italic></td><td valign="top"><named-content content-type="sequence">ATCGTTCAACTTGGACTTGG</named-content></td></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">Glutathione-S-Transferase-Raf1-Binding-Domain (GST-RBD)</td><td valign="top">This paper, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-017-01019-z">10.1038/s41467-017-01019-z</ext-link></td><td valign="top">For Ras-GTP assay</td><td valign="top">Purified from <italic>E. coli</italic> strain BL21 expressing pGEX2T-1-GST-RBD</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">PureLink RNA Mini kit</td><td valign="top">Thermo-Fisher</td><td valign="top">Cat #: 12183025</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">QuantiTect Reverse Transcription Kit</td><td valign="top">Qiagen</td><td valign="top">Cat #: 205313</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">iQ SYBR Green Supermix</td><td valign="top">BioRad</td><td valign="top">Cat #: 170–8882</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">LANCE cAMP 384 kit</td><td valign="top">Perkin Elmer</td><td valign="top">Cat #: AD0262</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">G418</td><td valign="top">Acros Organics</td><td valign="top">Cat #: 329400050</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">ClonNAT</td><td valign="top">Werner Bioagents</td><td valign="top">Cat #: 5.005.000</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Hygromycin B</td><td valign="top">Formedium</td><td valign="top">Cat #: HYG5000</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Phleomycin</td><td valign="top">Sigma Aldrich</td><td valign="top">P9564</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">5-fluoroorotic acid</td><td valign="top">Sigma Aldrich</td><td valign="top">F5013</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">EZ-Link Sulfo-NHS-LC Biotin</td><td valign="top">Thermo Fisher</td><td valign="top">Cat #: 21335</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Trichloroacetic acid</td><td valign="top">Sigma Aldrich</td><td valign="top">Cat #: T6399</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">KSCN</td><td valign="top">Sigma Aldrich</td><td valign="top">Cat #: P2713</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">(NH<sub>4</sub>)<sub>2</sub>Fe(SO<sub>4</sub>)<sub>2</sub> • 6 H2O</td><td valign="top">Sigma Aldrich</td><td valign="top">Cat #: 215406</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">TRIzol Reagent</td><td valign="top">Thermo Fisher</td><td valign="top">Cat #: 15596026</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DNase, RNase-free set</td><td valign="top">Qiagen</td><td valign="top">Cat #: 79254</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">cOmplete Mini EDTA-free protease inhibitor</td><td valign="top">Roche Applied Science</td><td valign="top">Cat #: 11873580001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Glutathione Sepharose beads</td><td valign="top">GE Healthcare</td><td valign="top">Cat #: 17-0756-01</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">12% Bis-Tris NUPAGE gels</td><td valign="top">Thermo FisherArch Biochem Biophys</td><td valign="top">Cat #: NP0349BOX</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">MOPS running buffer</td><td valign="top">Thermo Fisher</td><td valign="top">Cat #: NP0001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Immobilon-FL PVDF membrane</td><td valign="top">Millipore</td><td valign="top">Cat #: IPFL00010</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Ni<sup>2+</sup>-Sepharose beads</td><td valign="top">GE Healthcare</td><td valign="top">Cat #: 17-5318-06</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Anti-c-myc, agarose conjugated</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat #: A7470</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Trypsin Gold, mass spectrometry grade</td><td valign="top">Promega</td><td valign="top">Cat #: V5280</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">N-ethylmaleimide</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat #: E3876</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DYn-2</td><td valign="top">Cayman Chemical</td><td valign="top">Cat #: 11220</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">10% Criterion TGX Precast Midi Protein Gel</td><td valign="top">Bio-Rad</td><td valign="top">Cat #: 5671034</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Peptide Retention Time Calibration Mixture</td><td valign="top">Pierce, Thermo Fisher</td><td valign="top">Cat #: 88320</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MATLAB</td><td valign="top">Mathworks</td><td valign="top">version 2016b</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">CellX</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/0471142727.mb1422s101">10.1002/0471142727.mb1422s101</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Scrödinger Suite</td><td valign="top">Schrödinger LLC</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GROMACS</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.softx.2015.06.001">10.1016/j.softx.2015.06.001</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Amber tools</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/wcms.1121">10.1002/wcms.1121</ext-link></td><td valign="top"/><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Strains and growth conditions</title><p>Yeast strains and plasmids are listed in the Key resources table. The strains used in this study are derivatives of BY4741/BY4742. Strains were grown at 30°C in YPD 2% glucose (w/v) or in Yeast Nitrogen Base defined medium containing 2% glucose and complete supplement mixture (CSM) lacking the appropriate amino acids (Formedium) as described previously (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>). To check the segregation of deletion markers in tetrad dissections YPD medium supplied with the following chemicals was used to check segregation of the dominant markers: <italic>kanMX4</italic> (G418 200 µg/ml), <italic>natMX4</italic> (ClonNAT 100 µg/ml), <italic>hphMX4</italic> (Hygromycin B 300 µg/ml), <italic>bleMX4</italic> (Phleomycin 40 µg/ml). To counterselect the p<italic>TPK1-URA3</italic> plasmid cells were grown in defined glucose CSM –HIS, 5-FOA medium containing YNB, glucose and CSM –URA, HIS; 50 mg/l uracil and 1 g/l 5-fluoroorotic acid.</p></sec><sec id="s4-2"><title>Strain and plasmid constructions</title><p>Strains YMM170 (<italic>ras2∆tsa1∆)</italic> and YMM172 (<italic>pde2∆tsa1∆)</italic> were constructed by crossing strain YMM114 to BY4741 <italic>ras2∆::kanMX4</italic> and BY4741 <italic>pde2∆::kanMX4</italic> (Research Genetics, <xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>), respectively, and selecting for Mat alpha, methionine prototrophic, lysine auxotrophic, G418 resistant and nourseothricin resistant progeny. Strains YMM171 and YMM173 were constructed by crossing a BY4741 <italic>pde2∆::hphMX4</italic> {<italic>pde2∆::kanMX4</italic> from the deletion collection (Research Genetics, <xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>) marker-switched (<xref ref-type="bibr" rid="bib26">Goldstein and McCusker, 1999</xref>) to <italic>pde2∆::hphMX4</italic> to strain YMM170 (<italic>ras2∆tsa1∆</italic>) and selecting for Mat alpha, methionine prototrophic, lysine auxotrophic, G418 resistant, hygromycin resistant and nourseothricin sensitive (YMM171 <italic>ras2∆pde2∆</italic>) or nourseothricin resistant (YMM173 <italic>ras2∆pde2∆tsa1∆</italic>) progeny. Strains YMM174 (<italic>msn2∆msn4∆</italic>), YMM175 (<italic>pde2∆</italic>) and YMM176 (<italic>pde2∆</italic> o/e <italic>TSA1</italic>) were constructed by crossing BY4741 <italic>msn2∆msn4∆</italic> (<xref ref-type="bibr" rid="bib10">Caballero et al., 2011</xref>) or BY4741 <italic>pde2∆::kanMX4</italic> (Research Genetics, <xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>) to strains YMM130 or BY4742 <italic>his3∆1::pRS403-Myc-TSA1</italic>, respectively and selecting for Mat alpha, methionine prototrophic, lysine auxotrophic, histidine auxotrophic, hygromycin- and nourseothricin-resistant progeny (YMM174) or Mat alpha, methionine prototrophic, lysine auxotrophic, G418 resistant and histidine prototrophic progeny (YMM174 and YMM175). Strain YMM177 was constructed by marker-switching (<xref ref-type="bibr" rid="bib26">Goldstein and McCusker, 1999</xref>) a Mat a <italic>ras1∆::kanMX4</italic> spore, obtained from crossing strain BY4741 <italic>ras1∆::kanMX4</italic> Research Genetics, <xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>) to strain YMM114 and selecting for Mat a, methionine prototrophic, lysine auxotrophic and G418 resistant progeny, to <italic>ras1∆::hphMX4</italic>. Strain YMM178 (<italic>tpk1∆/TPK1 tpk2∆/TPK2 tpk3∆/TPK3</italic>) was constructed by crossing a BY4742 <italic>tpk1∆::kanMX4 tpk2∆::natMX4</italic> strain to a BY4741 <italic>tpk3∆::hphMX4</italic> strain {<italic>tpk3∆::kanMX4</italic> from the deletion collection [Research Genetics, (<xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>) marker-switched (<xref ref-type="bibr" rid="bib26">Goldstein and McCusker, 1999</xref>) to <italic>tpk3∆::hphMX4</italic> resulting in a <italic>tpk1Δ/TPK1 tpk2Δ/TPK2 tpk3Δ/TPK3</italic> heterozygous diploid strain. A Mat alpha, G418- and hygromycin-resistant spore constitutes strain YMM179 whereas a Mat alpha, nourseothricin- and hygromycin-resistant spore constitutes strain YMM180. The BY4742 <italic>tpk1∆::kanMX4 tpk2∆::natMX4</italic> strain was constructed by introducing <italic>tpk2∆::natMX4</italic> PCR amplified from a BY4742 <italic>tpk2∆::natMX4</italic> strain (<xref ref-type="bibr" rid="bib12">Costanzo et al., 2010</xref>) into strain BY4741 <italic>tpk1∆::kanMX4</italic> [Research Genetics, (<xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>) selecting for nourseothricin- and G418-resistance and verifying the deletion by diagnostic PCR. A BY4742 <italic>tpk1∆tpk2∆tpk3∆</italic> p<italic>TPK1-URA3</italic> haploid strain (YMM181) was constructed by transforming strain YMM177 with plasmid p<italic>TPK1-URA3</italic> and sporulating the strain selecting for a Mat alpha methionine prototrophic, lysine auxotrophic, G418-, nourseothricin-, hygromycin B-resistant and uracil auxotrophic progeny. Strains YMM182-YMM186 were constructed by transforming strain YMM180 with plasmids pRS313 (YMM181), pRS313-<italic>TPK1</italic> (YMM183), pRS313-<italic>tpk1C243A</italic> (YMM184) and pRS313-<italic>tpk1C243D</italic> (YMM185) and pRS313-<italic>tpk1T241A</italic> (YMM186). Counterselecting p<italic>TPK1-URA3</italic> on 5-FOA medium resulted in strains YMM187 (BY4742 <italic>tpk1∆tpk2∆tpk3∆</italic> pRS313-<italic>TPK1</italic>), YMM188 (BY4742 <italic>tpk1∆tpk2∆tpk3∆</italic> pRS313-<italic>tpk1C243A</italic>), YMM189 (BY4742 <italic>tpk1∆tpk2∆tpk3∆</italic> pRS313-<italic>tpk1C243D</italic>) and yMM190 (BY4742 <italic>tpk1∆tpk2∆tpk3∆</italic> pRS313-<italic>tpk1T241A</italic>), respectively. Strain YMM191 (<italic>ras2∆trx1∆trx2∆</italic>) was constructed by crossing strain YMM113 (<italic>ras2∆</italic>) to strain YMM143 (<italic>trx1∆trx2∆</italic>) selecting for Mat alpha, methionine prototrophic, lysine auxotrophic, G418-, nourseothricin- and hygromycin B-resistant progeny. Strain YMM192 was constructed by marker-switching strain BY4741 <italic>tsa1∆::kanMX4</italic> [Research Genetics, (<xref ref-type="bibr" rid="bib25">Giaever et al., 2002</xref>) into BY4741 <italic>tsa1∆::bleMX4</italic> using a bleMX4 cassette PCR amplified from plasmid pUG66 (<xref ref-type="bibr" rid="bib28">Gueldener et al., 2002</xref>) using primers PR78 and PR79 (<xref ref-type="bibr" rid="bib26">Goldstein and McCusker, 1999</xref>). Strain yMM193 was constructed by crossing strains yMM180 and yMM192 selecting for a Mat a, nourseothricin+, hygromycin+ and phleomycin+ spore. Strain WR1832 was constructed by first introducing PCR amplified <italic>trp1Δ::kanMX4</italic> DNA (<xref ref-type="bibr" rid="bib47">Longtine et al., 1998</xref>) into strain YMM180, verification of cassette integration by PCR and loss of the ability to grow without tryptophan supplement and next by <italic>HBH::TRP1</italic> C-terminal tagging of <italic>TPK1</italic> and PCR based verification as described (<xref ref-type="bibr" rid="bib73">Tagwerker et al., 2006</xref>). Strains yCP101-yCP104 were constructed by crossing Mat a <italic>his3Δ1::pRS403</italic> or <italic>his3Δ1::pRS403-myc-TSA1</italic> spores, obtained in crosses generating strains yMM175 above, either to strain yMM183 or to strain yMM187 also carrying plasmid <italic>pRS316-tpk1C243A</italic>. Methionine prototrophic, lysine auxotrophic, histidine prototrophic, 5-FOA-sensitive, G418+, nourseothricin+ and hygromycin B+ progeny obtained in these crosses constitute strains yCP101-yCP104 listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> Table S1. Strains yCP105 and yCP106 were constructed by crossing strains yMM187 (p<italic>TPK1</italic>) or yMM189 (p<italic>tpk1T241A</italic>), respectively, to strain yMM192 selecting for Mat alpha, Met+, Lys-, G418+, Nat+, Hyg+, Phleomycin+, His+ progeny. Strain yCP107 was constructed by crossing strain WR1832 to yMM193 and selecting for Mat alpha, Met+, Lys-, G418+, Nat+, Hyg+, Phleomycin+, Trp+ progeny.</p><p>Plasmids pRS313-<italic>tpk1C243A</italic>, pRS313-<italic>tpk1C243D</italic>, pRS313-<italic>tpk1T241A</italic> and pRS316-<italic>tpk1C243A</italic>, were constructed by site directed mutagenesis of the pRS313-<italic>TPK1</italic> or pRS316-<italic>TPK1</italic> plasmids (Eurofins Genomics). Plasmids pRS315-<italic>trx1C34S</italic>-ProtA and pRS315-<italic>trx2C31SC34S</italic>-ProtA were constructed by site-directed mutagenesis of plasmid pRS315-<italic>TRX2</italic>-ProtA (GenScript). The correct sequence of all plasmids constructed was verified by sequencing.</p></sec><sec id="s4-3"><title>Lifespan analyses</title><p>Lifespan analyses were performed as previously described by counting the number of daughters produced in a cohort of mother cells (<xref ref-type="bibr" rid="bib19">Erjavec et al., 2007</xref>).</p></sec><sec id="s4-4"><title>2D-page</title><p>Protein synthesis rates of the indicated proteins were determined in <sup>35</sup>S-Methionine labelled protein extracts separated by two-dimensional polyacrylamide gel electrophoresis as described (<xref ref-type="bibr" rid="bib48">Maillet et al., 1996</xref>; <xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>). Tsa1 sulfinylation was determined by comparing levels of sulfinylated Tsa1 (Tsa1-SOOH) to non-sulfinylated Tsa1 on silver-stained 2D gels as described (<xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>).</p></sec><sec id="s4-5"><title>Spot tests</title><p>H<sub>2</sub>O<sub>2</sub> resistance was tested with mid-exponential-phase (A<sub>600</sub> = 0.3, 3 × 10<sup>6</sup> cells/ml) cells that were diluted (x5, x50, x500, x5000, x50000) and spotted onto SD media containing 0 to 1 mM H<sub>2</sub>O<sub>2</sub> or YPD media containing 0 to 2 mM. The number of colonies after 2 days incubation at 30 ◦C on H<sub>2</sub>O<sub>2</sub> plates was divided with the number on control plates to get H<sub>2</sub>O<sub>2</sub>-resistance (%).</p><p>For glycogen accumulation, plates incubated for 2 days at 30 ◦C were exposed to iodine-bead fumes for 2.5 min and scanned immediately.</p></sec><sec id="s4-6"><title>Spore viability</title><p>The viability of spores segregating in the sporulation and dissection of a heterozygous diploid <italic>ras1∆:: hphMX4/RAS1 ras2∆::kanMX4/RAS2 tsa1∆::natMX4/TSA1</italic> strain obtained by crossing strain YMM176 (<italic>ras1∆::hphMX4</italic>) to strain YMM170 (BY4742 <italic>ras2∆::kanMX4 tsa1∆::natMX4</italic>) was analyzed after 4 days of incubation at 30<sup>◦</sup>C in 32 tetrads where 1) all markers analyzed (<italic>hphMX4, kanMX4, natMX4, MET15, LYS2</italic>) segregated 2:2, 2) the exact genotypes of all spores were possible to deduce from this information and 3) the genotypes of dead spores were assigned based on markers present in the other spores dissected from the same tetrads. Similarly, spore viability of spores segregating in a heterozygous diploid <italic>tpk1∆::kanMX4/TPK1 tpk2∆::natMX4/TPK2 tpk3∆::hphMX4/TPK3 tsa1∆::bleMX4/TSA1</italic>, obtained by crossing strain YMM191 (BY4741 <italic>tsa1∆::bleMX4</italic>) to strain YMM186 (BY4742 <italic>tpk1∆::kanMX4 tpk2∆::natMX4 tpk3∆::hphMX4</italic> expressing pRS313-<italic>TPK1</italic>), was analyzed in 43 tetrads where all chromosomal markers analyzed (<italic>kanMX4, natMX4, hphMX4, bleMX4, MET15, LYS2</italic>) segregated 2:2. The ability to grow in the absence of histidine supplementation (-HIS) was taken as an indication that the pRS313-<italic>TPK1</italic> plasmid was present.</p></sec><sec id="s4-7"><title>Quantitative Real-Time PCR analysis</title><p>Cell cultures were harvested in mid-exponential phase and resuspended in 1 ml Trizol Reagent (Invit- rogen) and homogenized with silica beads by Fast prep (6.5 m/s, 30 s, interval 2.5 min, 4 °C). RNA was extracted using phenol chloroform extraction and precipitated with sodium acetate/ethanol. The pellet was treated with DNase for 30 min followed by heat-inactivation of the enzyme. The RNA was purified with Invitrogen PureLink RNA Mini Kit columns and converted to cDNA following the QIAGEN QuantiTect Reverse Transcription Kit. Q-PCR was performed with 50 ng cDNA by using BioRad iQ SYBR Green Supermix and quantified with the BioRad iCycler, iQ5. Relative levels of mRNA were calculated by using cycle times of <italic>ACT1</italic> as a reference gene.</p></sec><sec id="s4-8"><title>Quantitative analyses of Msn2-GFP localization</title><p>Msn2-signaling was analyzed as described previously (<xref ref-type="bibr" rid="bib6">Bodvard et al., 2017</xref>). Briefly, the fraction of cells displaying nuclear localization of Msn2-GFP (nucleus/cytoplasm signal ratio &gt;1.28) at each time point was calculated and used to calculate the total time Msn2 spent in the nucleus during a 60 min experiment.</p></sec><sec id="s4-9"><title>Measurement of Ras2-GTP in vivo</title><p>Ras2-GTP level was measured as a ratio between Ras2-GTP and total Ras2 as described previously (<xref ref-type="bibr" rid="bib11">Colombo and Martegani, 2014</xref>; <xref ref-type="bibr" rid="bib61">Peeters et al., 2017</xref>). Mid-exponential phase yeast cells were harvested and lysed with glass- beads in Fast-prep (6.0 m/s, 20 s, interval 2.5 min) in lysis buffer [50 mM Tris-HCl, 200 mM NaCl, 2.5 mM MgCl<sub>2</sub>, 10% glycerol, 1% Triton X100, cOmplete Protease inhibitor EDTA-free]. The supernatant with 1.5 mg of total protein was incubated with a bed volume 50 µL of glutathione S-transferase (GST)-RBD fusion protein pre-bound to glutathione-Sepharose for 1 hr at 4 °C and washed three times with lysis buffer by centrifugation. For elution the beads were boiled for 5 min at 98 °C in SDS-sample buffer (6% SDS, 62.5 mM Tris-HCl pH 8.7, 30% Glycerol, 0.75% β-mercaptoethanol). Through western blotting, Ras2-GTP and total Ras2 proteins were detected with anti-Ras2 antibodies. Determination of ratios between Ras2-GTP and total Ras2 was performed by ImageJ.</p><p>cAMP measurement cAMP measurements were performed as previously described (<xref ref-type="bibr" rid="bib10">Caballero et al., 2011</xref>; <xref ref-type="bibr" rid="bib60">Parts et al., 2011</xref>). 2 × 10<sup>8</sup> cells grown to midexponential phase were pelleted, washed, and resuspended in 1 ml cold milliQ water. Metabolites were extracted by adding 1.2 ml TCA (0.5 M) and occasional vigourous vortexing while samples were kept on ice for 15 min. TCA was removed by ether extraction. cAMP levels were determined by the LANCE cAMP 384 kit in 40 µL total reactions and by comparing to the standards supplied. The values for cAMP were normalized to the wild type level.</p></sec><sec id="s4-10"><title>Global H<sub>2</sub>O<sub>2</sub> scavenging in the medium</title><p>Medium peroxide determinations were performed using a ferrithiocyanate spectrophotometric assay (<xref ref-type="bibr" rid="bib51">Molin et al., 2007</xref>). After bolus addition of H<sub>2</sub>O<sub>2</sub>, 100 µL sample aliquots were withdrawn and cultures were arrested by the addition of 1 ml ice-cold 10% TCA. After pelleting cells 180 mM KSCN and 1.4 mM Fe(NH<sub>4</sub>)<sub>2</sub>(SO<sub>4</sub>)<sub>2</sub> final concentrations were added to the supernatants. Absorbance at 480 nm was subsequently determined and compared to equally TCA-treated H<sub>2</sub>O<sub>2</sub> standards diluted in medium.</p></sec><sec id="s4-11"><title>Isolation of old cells</title><p>Old cells were obtained as previously described by sorting biotin-labeled mother cells using the MagnaBind streptavidin system (<xref ref-type="bibr" rid="bib67">Sinclair and Guarente, 1997</xref>). Briefly, mid-exponential phase cells were labeled with EZ-Link Sulfo-NHS-LC Biotin and grown overnight in minimal media (CSM-His). The cells were incubated with streptavidin-conjugated magnetic beads for 2 hr and then sorted magnetically with the unlabeled cells being washed away. Sorted cells were then grown overnight and the streptavidin labeling procedure was repeated before sorting one last time. After sorting the cells were incubated for 1 hr in CSM-His media at 30 ◦C for recovery before microscopy.</p></sec><sec id="s4-12"><title>Measurements of cytoplasmic H<sub>2</sub>O<sub>2</sub> using HyPer3</title><p>Fluorescence of the ratiometric probe HyPer-3 (<xref ref-type="bibr" rid="bib4">Bilan et al., 2013</xref>) was acquired using an Olympus IX81 motorized microscope with a PlanApoN 60x/1.42 Oil objective and a 12-bit Hamamatsu camera. Shifts in the fluorescence intensities were acquired with excitation around 500 nm (485/20 nm) and 420 nm (427/10 nm filter) and an emission filter around 520 nm (Fura two filter). For bolus addition of H<sub>2</sub>O<sub>2</sub>, cells in midexponential phase were incubated with 0.2 mM H<sub>2</sub>O<sub>2</sub> for 10 min and immediately imaged.</p></sec><sec id="s4-13"><title>Image analysis of HyPer3 fluorescence</title><p>Image and signal analysis was performed using the MATLAB toolbox 2016b. Cell segmentation is performed with the CellX algorithm using the bright-field channel. The fluorescent intensity data were obtained from fluorescent images and data are presented as the median 500 nm fluorescent signal normalized to the median fluorescent 420 nm signal by dividing the latter with the former.</p></sec><sec id="s4-14"><title>AKAR4 FRET-based PKA activity measurements</title><p>Detection of cyan fluorescent protein CFP to yellow fluorescent protein YFP FRET in the AKAR4 sensor was performed as described previously (<xref ref-type="bibr" rid="bib17">Depry and Zhang, 2011</xref>; <xref ref-type="bibr" rid="bib53">Molin et al., 2020</xref>). CFP was excited at 427/10 nm, YFP was excited at 504/6 nm and emission was monitored using a Semrock dual bandpass filter (part no: FF01-464/547). Images were acquired using an automated epi-fluorescence microscope (Olympus IX81) equipped with a × 60 oil-immersion objective (numerical aperture 1.4, PlanApoN ×60/1.42 Oil, Olympus) and an electron-multiplying charge-coupled device camera (12-bit Hamamatsu camera). The yeast cells were kept in a heated perfusion chamber (FCS2, Bioptechs Inc) at 28°C to avoid heat-induced stress responses. The objective was heated to 26.2°C (according to the manufacturer’s instructions) to maintain a stable temperature in the perfusion chamber. The cover glasses were precoated for 1.5 hr with protein concanavalin A, 0.5 μg μl−1 in 0.01 M PBS, to immobilize yeast cells on the surface.</p></sec><sec id="s4-15"><title>Immunoprecipitation</title><p>Cells from 50 mL/sample of mid-exponential phase YPD culture was pelleted, the pellet was washed with cold water and pelleted again, washed with 1 mL lysis buffer (50 mM Tris HCl pH 8.0, 150 mM NaCl, 1 mM EDTA, 10% Glycerol, 5 mM MgCl<sub>2</sub> and protease-inhibitor cocktail). Cells were broken in 0.35 mL lysis buffer by beads at four degrees in a Fastprep FP120 cell disrupter (Bio101/ThermoSavant, speed 5 m/sec, 4 times 40 s with &gt;1 min on ice in between each agitation). The extract was pelleted at 12500 rpm at four degrees and the supernatant was used for subsequent analyses. An aliquot of supernatant was withdrawn for analysis of input protein levels (load sample). Beads were prewashed with lysis-buffer (100 µL) before incubated with protein extract (300 µL at 1 ug/µL) at four degrees overnight. Beads were pelleted by centrifugation at 1000 rpm, 1 min, washed three times with lysis buffer and boiled at 95°C, 5 min with Laemmli buffer (IP sample). 10 µL of each sample was separated on an SDS-PAGE gel for 1.5 hr at 120V an blotted as described below. Membranes were incubated overnight with the primary antibody at 4 degrees.</p></sec><sec id="s4-16"><title>Immunoblot analysis</title><p>Immunoblot analysis of selected proteins was performed as described previously (<xref ref-type="bibr" rid="bib5">Biteau et al., 2003</xref>; <xref ref-type="bibr" rid="bib52">Molin et al., 2011</xref>). Prior to separation on 12% Bis-Tris NuPAGE gels using an XCell SureLock MiniCell (Invitrogen) in NuPAGE MOPS running buffer as recommended by the supplier protein extracts were heated in Laemlii buffer (pH 8.7) either in the presence of β-mercaptoethanol (5%, reducing) or not (non-reducing) as indicated. Transfer to Immobilon-FL PVDF membranes was done using an XCell II Blot Module kit. Membranes were analyzed by the Odyssey infrared imaging system (LI-COR biosciences) as recommended by the suppliers.</p><p>Glutathionylation of Tpk1 was assayed using anti-glutathione immunoblot on Tpk1-HB immunoprecipitated by Ni<sup>2+</sup>-Sepharose beads following a simplified protocol similar to that used during MS sample preparation (see below). We verified that the anti-glutathione immunoblot signal in Tpk1 completely disappeared upon extract reduction by β-mercaptoethanol.</p></sec><sec id="s4-17"><title>Growth conditions for MS analysis</title><p>Cells were grown at 30°C in yeast extract/peptone (YP) medium, containing 2% glucose as carbon source. Three independent experimental replicates were performed for each experimental condition. For each replicate, we inoculated 750 ml YPD cultures, which were incubated (with shaking) overnight until OD600 = 1. Oxidative stress was induced by adding 0.4 mM or 0.8 mM (final concentration) H<sub>2</sub>O<sub>2</sub> for 10 min.</p></sec><sec id="s4-18"><title>Mass spectrometric sample preparation</title><p>HB (poly histidine, biotinylation signal) tandem affinity purifications were performed as described elsewhere (<xref ref-type="bibr" rid="bib64">Reiter et al., 2012</xref>). Cells were harvested by filtration and immediately deep-frozen in liquid N<sub>2</sub>. Cells were grinded using a SPEX Freezer Mill 6870 (SPEXSamplePrep, Metuchen, NJ, USA) with the following settings: 7 cycles: 3 min breakage (15 CPS), 3 min cooling, resuspended in buffer 1 (6 M guanidine HCl, 50 mM Tris pH8.0, 5 mM NaF, 1 mM PMSF, 0.1% Tween, cOmplete Protease inhibitor cocktail, pH 8) and cleared of debris by centrifugation 13.500 x g, 15 min, 4°C. Cleared extracts were incubated (4 hr, room temperature) with Ni<sup>2+</sup>-Sepharose beads, washed with urea buffer (8M urea, 50 mM sodium phosphate buffer pH8.0, 300 mM NaCl, 0.1% Tween20) and urea buffer pH 6.3. Proteins were eluted in urea buffer pH 4.3 containing 10 mM EDTA, incubated overnight with streptavidin-agarose beads, washed using urea wash buffer containing 1% SDS and urea wash buffer without SDS. Beads were washed five times with 50 mM ammonium bicarbonate (ABC). Cys-residues were alkylated with IAA (25% w/w of the estimated amount of protein). Excess IAA was washed out by ABC. Proteins were digested with 300 ng trypsin at 37°C overnight. Digestion was stopped with trifluoroacetic acid (0.5% final concentration) and the peptides were desalted using C18 Stagetips (<xref ref-type="bibr" rid="bib63">Rappsilber et al., 2007</xref>). 50 fmol of the Peptide Retention Time Calibration Mixture was spiked in each sample for quality control.</p></sec><sec id="s4-19"><title>Mass spectrometry analysis of Tpk1</title><p>Peptides were separated on an Ultimate 3000 RSLC nano-flow chromatography system (Thermo-Fisher), using a pre-column (Acclaim PepMap C<sub>18</sub>, 2 cm ×0.1 mm, 5 μm, Thermo-Fisher), and a C<sub>18</sub> analytical column (Acclaim PepMap C18, 50 cm ×0.75 mm, 2 μm, Thermo-Fisher). A segmented linear gradient from 2% to 35% solvent B (solvent B: 80% acetonitrile, 0.1% formic acid; solvent A: 0.1% formic acid) was applied at a flow rate of 230 nL/min over 120 min. A Proxeon nanospray flex ion source (Thermo Fisher) using coated emitter tips (New Objective) was used for ionization. The capillary temperature was set to 200°C. Peptides were analyzed on an Orbitrap Fusion Lumos Tribrid mass spectrometer (Thermo Fisher). The mass spectrometer was operated in data-dependent mode, survey scans were obtained in a mass range of 380–1500 m/z with lock mass activated, at a resolution of 120,000 at 200 m/z and an automatic gain control (AGC) target value of 4E5. The maximum cycle time was set to 2.5 s and the most abundant precursors were selected for fragmentation by high-energy collision at 30% collision energy. Fragmented precursors were excluded from further fragmentation for 30 s (with +/- 5 ppm accuracy) and peptides with charge +one or &gt; +six were excluded from MS/MS analysis. The most abundant Tpk1 Cys containing peptide forms have been added to an inclusion list as specified in the raw files. MS proteomics data have been deposited to the ProteomeXchange Consortium through the Proteomics Identifications database (PRIDE) partner repository (<xref ref-type="bibr" rid="bib76">Vizcaíno et al., 2016</xref>) with the data set identifiers PXD012617.</p></sec><sec id="s4-20"><title>Closed database search</title><p>Peptide identification and label free quantification (LFQ) were performed using MaxQuant (version 1.6.0.16) with default parameters. <italic>Saccharomyces cerevisiae</italic> reference proteome database (UniProt, version January 2017) in combination with a common laboratory contaminants database (MQ) was used for peptide spectrum matching. N-terminal acetylation, deamidation of asparagine and glutamine, oxidation of methionine, tri-oxidation and glutathionylation of cysteine and phosphorylation of serine, threonine and tyrosine were set as variable protein modification. Carbamidomethylation of cysteine was set as fixed. A maximum of 5 variable modifications per peptide was allowed. Leucine and isoleucine were treated as indistinguishable. Enzyme specificity was set to ‘Trypsin/P’. A maximum of 2 missed cleavages per peptide was allowed. ‘Requantify’ and ‘Match between runs’ was activated. MaxLFQ (implemented in the MaxQuant package) was used for MS1-based label free quantification and normalization of protein groups.</p></sec><sec id="s4-21"><title>Open database search of selected peptides</title><p>To screen for protein modifications in an unbiased manner we initially performed an open search using MSFragger in FragPipe (<xref ref-type="bibr" rid="bib41">Kong et al., 2017</xref>). The default open search parameters were used, with trypsin specificity, +/- 500 Da windows and oxidation of methionine and carbamidomethylation of cysteine as variable modifications. The observed mass shifts were inspected and filtered for the most abundant and relevant modifications occurring in Tpk1.</p></sec><sec id="s4-22"><title>Targeted mass-spectrometry</title><p>Parallel-Reaction-Monitoring (PRM) assays were generated based on the peptide information obtained by MaxQuant. We selected Tpk1 peptides for targeted relative LFQ as specified in Supplementary file 1D .Peptides were separated using a 120 min gradient (HPLC setup as described above). PRM data acquisition was performed using a scheduled method with 20 min windows for each target based on the retention time determined in the shotgun-approach. Raw data were obtained on an Orbitrap Q Exactive HF-X (Thermo Fisher Scientific) mass spectrometer applying the following settings: survey scan with 60 k resolution, AGC 1E6, 60 ms IT, over a range of 400 to 1400 m/z, PRM scan with 30 k resolution, AGC 1E5, 200 ms IT, isolation window of 1.0 m/z with 0.3 m/z offset, and NCE of 27%.</p><p>Wash runs were checked for potential peptide carry-over in between samples using same HPLC and MS methods. Data analysis, manual validation of all transitions (based on retention time, relative ion intensities, and mass accuracy), and relative quantification was performed in Skyline. Up to six characteristic transitions were selected for each peptide and their peak areas were summed for peptide quantification (total peak area). MS1 signals of PRTC standards were used as global standards for normalization in Skyline to account for fluctuations in instrument performance. The mean of the log2 Tpk1 non-modified peptide intensities was used to normalize Tpk1 modified peptides and Tsa1 peptides to account for differences in Tpk1 levels. Tsa1 peptide intensities (anti-log) were summed up to obtain values for relative protein abundance.</p></sec><sec id="s4-23"><title>Cysteine sulfenylation assay by DYn-2 labeling, protein extraction and click chemistry</title><p>Mid-exponential cells (10 ml at OD<sub>600</sub> = 0.5) were treated with of DYn-2 (0.5 mM) for 30 min, at 30°C and cell suspensions were next exposed to 0.5 mM H<sub>2</sub>O<sub>2</sub>for 5 min. To the cultures trichloroacetic acid (TCA) was added to a final concentration of 20%, followed by centrifugation (6000 x g, 5 min, 4°C) and pellets were lysed with glass beads (equivalent of 0.1 ml of beads) in 0.2 ml of TCA (20%). Lysates were centirfuged (14000 x g, 15 min, 4°C) and pellets were washed twice with acetone, dried and solubilized in 0.2 ml Hepes (100 mM) buffer containing cOmplete mini EDTA-free protease inhibitor cocktail (Roche) (one tablet/20 ml of buffer solution), 25 µg/ml phenylmethylsulfonylfluoride, 0.1% Nonidet P-40, 2% SDS, pH 7.4. Protein content was determined using a standard DC Protein Assay (Bio-Rad). A copper (I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry reaction was performed on 0.2 mg of protein as previously described (<xref ref-type="bibr" rid="bib75">Truong and Carroll, 2012</xref>; <xref ref-type="bibr" rid="bib79">Yang et al., 2015</xref>). Briefly, cyanine5 azide (0.5 mM), copper(II)-TBTA complex (1 mM) and ascorbate (2 mM) were added to the lysates, protected from light and incubated for 1 hr at room temperature under rotation. The CuAAC reaction was quenched by adding EDTA (1 mM) for 10 min. The solution was precipitated by methanol/chloroform precipitation (sample/methanol/chloroform, 4/4/1 (v/v/v)) and centrifuged (14000 x g, 15 min, 4°C). The protein pellet obtained were between the organic and aqueous layers, both layers were aspirated. A solution of methanol/chloroform (H<sub>2</sub>O/methanol/chloroform, 4/4/1 (v/v/v) was added to the protein pellet and centrifuged (14000 x g, 15 min, 4°C). Both layers were aspirated and the obtained pellet was subsequently washed twice with methanol. Protein pellets were resuspended in 100 mM Hepes buffer containing 2% SDS. Biotinylated proteins were enriched with Pierce streptavidin bead (Thermo Scientific). The protein pellets were mixed to a pre-washed streptavidin beads (100 mM Hepes buffer). The samples were incubated for 2 hr at room temperature and subsequently washed twice with 1% SDS, twice with 4M urea, once with 1M NaCl and twice with PBS. After each wash step, beads were collected by centrifugation. Beads were finally resuspended in 5X Laemmli buffer and boiled for 5 min at 95°C. Samples were resolved by SDS-PAGE and analyzed for fluorescence at 700 nm (Cyanine5) on an Odyssey CLx (Licor).</p></sec><sec id="s4-24"><title>Homology modeling</title><p>A model of the yeast PKA tetramer structure was obtained by homology modeling. The protein sequences of yeast Tpk1 (catalytic subunit of PKA) and Bcy1 (regulatory subunit of PKA) were obtained from Genbank (ID: 1023942850 and ID: 1023943330, respectively). The crystal structure of mouse PKA (PDBID: 3TNP) was used as the template for the homology calculations. The catalytic and regulatory subunits of yeast PKA and mouse PKA shares 48% and 42% sequence similarity, respectively. The homology model was built using StructurePrediction panel (<xref ref-type="bibr" rid="bib37">Jacobson et al., 2002</xref>) in Schrödinger Suite (Schrödinger, LLC, New York, NY). The ClustralW method was used to align the target and template sequences in Prime, the energy-based was selected for model building method, and homo-multimer was selected for multi-template model type.</p></sec><sec id="s4-25"><title>Covalent docking</title><p>Covalent docking was carried out to obtain a model for glutathionylated Tpk1. The Tpk1 crystal structure (PDB ID: 1FOT, <xref ref-type="bibr" rid="bib49">Mashhoon et al., 2001</xref>) were prepared using the Protein Preparation utility in Schrodinger to assign the correct protonation state and fix the missing side chains and loops. The glutathione was built by 3D builder and prepared by LigPre utility in Schrodinger. The Covalent-Dock panel (<xref ref-type="bibr" rid="bib84">Zhu et al., 2014</xref>) in Schrodinger was used to predict the pose of the glutathione attaching to Cys243. The reaction type was set to be disulfide formation, the docking mode was set to be thorough pose prediction, the other parameters were all set to be default. At the final step, Prime Energy was used to rank the poses of the ligand. Covalent docking was performed on dephosphorylated Tpk1 structure.</p></sec><sec id="s4-26"><title>Molecular dynamics simulations</title><p>Molecular dynamics simulations were carried out to study structural changes of Tpk1 upon phosphorylation and glutathionylation. MD simulations non-modified Tpk1, Cys243 glutathionylation Tpk1, Thr241 phosphorylation Tpk1, Cys243 glutathionylation and Tpk1 phosphorylation co-existed Tpk1 were carried out. The GROMACS software (<xref ref-type="bibr" rid="bib1">Abraham et al., 2015</xref>) was used for the MD simulations and the Amber 99 (<xref ref-type="bibr" rid="bib62">Ponder and Case, 2003</xref>) force field was selected to assign the parameters for different amino acid residues. The glutathionylation and phosphorylation parameters was generated from Ambertools, and incorporated into the GROMACS software.</p><p>The systems were solvated with a buffer distance of 10.0 Å TIP3P water in periodic boxes, and then 0.1 mol/L of Na+ and Cl− ions were added to adjust the systems to electroneutrality condition. Then 200 steps of the steepest descent energy minimization was carried out to remove close contacts in the obtained systems. A 2ns position-restrained simulation with a constant pressure ensemble (NPT) was performed to make sure the water molecules would reach more favorable positions. The parameters for position-restrained simulation are set to be: a time step = 1 fs, temperature = 298 K, and coupling pressure = 1 bar, Coulomb cutoff = 10 Å, Lennard-Jones cutoff = 10 Å, particle-mesh Ewald summation (<xref ref-type="bibr" rid="bib13">Darden et al., 1993</xref>; <xref ref-type="bibr" rid="bib20">Essmann et al., 1995</xref>) was used for longrange electrostics. The temperature and pressure was controlled by Berendsen coupling algorithm (<xref ref-type="bibr" rid="bib3">Berendsen et al., 1984</xref>), with the time constants of 0.1 ps for temperature and 1.0 ps for pressure coupling. All bond lengths were contrained by the LINCS algorithm (<xref ref-type="bibr" rid="bib32">Hess et al., 1997</xref>). Following the position-restrained simulation, 100 ns production simulations with NPT ensemble were performed on each system for further study the protein conformational changes. In this step, the Nose−́ Hoover thermostat (<xref ref-type="bibr" rid="bib33">Hoover, 1985</xref>), with a time constant 0.1 ps, was used to control the temperature and the Parrinello−Rahman barostat (<xref ref-type="bibr" rid="bib59">Parrinello and Rahman, 1981</xref>), with a time constant 1.0 ps, was used to control the pressure. The other parameters were the same as those in the position-restrained simulations.</p></sec><sec id="s4-27"><title>Quantification and statistical analysis</title><p>All experiments were repeated at least three times (biological replicates) to ensure reproducibility. Biological replicates of experiments were performed in separate, independent experiments (typically on a separate day). No data were excluded in averages/median values presented in figures. Details on the number of replicates and statistical analyses performed in relation to the specific figures are available below.</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref> (B) Lifespans were tested for statistical significance by the Mann-Whitney U test (<ext-link ext-link-type="uri" xlink:href="http://www.socscistatistics.com/tests/mannwhitney/Default2.aspx">www.socscistatistics.com/tests/mannwhitney/Default2.aspx</ext-link>). B) Lifespans of wt control and o/e <italic>TSA1</italic> strains are significantly different using the Mann Whitney U test (n = 167 and 168 cells, p&lt;0.00001). Lifespans of <italic>pde2Δ</italic> control and <italic>pde2Δ</italic> o/e <italic>TSA1</italic> strains are not significantly different (n = 81 and 84, respectively, p=0.58). D) Hsp12 levels are significantly different between control and o/e <italic>TSA1</italic> strains (n = 3, p=0.033) whereas Act1 levels are not (n = 3, p=0.69). E) Lifespans of the wt (n = 157) vs the <italic>tsa1Δ</italic> (n = 293) and the <italic>tsa1Δ</italic> vs <italic>ras2Δtsa1Δ</italic> (n = 283) are significantly different at p&lt;0.00001. The lifespan of the <italic>ras2Δ</italic> (n = 138) is not significantly different from the <italic>ras2Δtsa1Δ</italic> (p=0.276). F) Lifespans of the wt (n = 157) vs the <italic>pde2Δ</italic> (n = 120), the <italic>ras2Δtsa1Δ</italic> vs <italic>ras2Δpde2Δtsa1Δ</italic> (n = 164) and the <italic>tsa1Δ</italic> (n = 293) vs <italic>pde2Δtsa1Δ</italic> (n = 242) are significantly different at p&lt;0.00001. Lifespans of the <italic>ras2Δpde2Δ</italic> (n = 124) vs <italic>pde2Δ</italic> are significantly different (p=0.00068) whereas the lifespans of <italic>pde2Δ</italic> vs <italic>pde2Δtsa1Δ</italic> are not significantly different (p=0.757).</p><p><xref ref-type="fig" rid="fig2">Figure 2</xref> (A) Doubling times of wt and <italic>ras2Δ</italic> strains are significantly different at p=0.047 whereas the difference between the <italic>tsa1Δ</italic> and the <italic>ras2Δtsa1Δ</italic> is not statistically significant using a two-sided t-test assuming equal variance (p=0.77). C) Doubling times of control and mc-<italic>IRA2</italic> strains are significantly different for the wt (n = 7 each, p=7.4×10<sup>−6</sup>), the <italic>tsa1ΔYF</italic> (n = 3 and 4, respectively, p=0.0032), <italic>msn2Δmsn4Δ</italic> (n = 3 each, p=0.026) and <italic>trx1Δtrx2Δ</italic> (n = 15 and 13, respectively, p=0.012). In none of the other strains are control and mc-<italic>IRA2</italic> different (<italic>tsa1Δ</italic> n = 3 each, p=0.87; <italic>tsa1C48S</italic>, n = 3 each, p=0.71; <italic>tsa1C171S</italic>, n = 4 each, p=0.11; <italic>tsa1ΔYFC171S</italic>, n = 4 each, p=0.77; <italic>pde2Δ</italic>, n = 3 each, p=0.66. D) Relative <italic>HSP12</italic> levels were significantly different between wt control and mc-<italic>IRA2</italic> strains (n = 15 and 9, respectively, p=1.0×10<sup>−14</sup>), between wt mc-<italic>IRA2</italic> and <italic>tsa1Δ</italic> mc-<italic>IRA2</italic> strains (n = 9 and 8, respectively, p=1.9×10<sup>−6</sup>), between wt mc-<italic>IRA2</italic> and <italic>tsa1C171S</italic> mc-<italic>IRA2</italic> strains (n = 9 and 4, respectively, p=0.026), between wt mc-<italic>IRA2</italic> and <italic>tsa1ΔYFC171S</italic> mc-<italic>IRA2</italic> strains (n = 9 and 6, respectively, p=0.00083) and between wt mc-<italic>IRA2</italic> and <italic>pde2Δ</italic> mc-<italic>IRA2</italic> strains (n = 9 and 6, respectively, p=4.8×10<sup>−8</sup>). No significant difference was seen between wt mc-<italic>IRA2</italic> and <italic>tsa1ΔYF</italic> mc-<italic>IRA2</italic> strains (n = 9 and 3, respectively, p=0.53). Relative <italic>CTT1</italic> levels were significantly different between wt control and mc-<italic>IRA2</italic> strains (n = 24 and 21, respectively, p=3.4×10<sup>−13</sup>), between wt mc-<italic>IRA2</italic> and <italic>tsa1Δ</italic> mc-<italic>IRA2</italic> strains (n = 21 and 6, respectively, p=0.0073), between wt mc-<italic>IRA2</italic> and <italic>tsa1C171S</italic> mc-<italic>IRA2</italic> strains (n = 9 and 4, respectively, p=0.026), between wt mc-<italic>IRA2</italic> and <italic>tsa1ΔYF</italic> mc-<italic>IRA2</italic> strains (n = 21 and 3, respectively, p=0.027), between wt mc-<italic>IRA2</italic> and <italic>tsa1ΔYFC171S</italic> mc-<italic>IRA2</italic> strains (n = 21 and 6, respectively, p=p = 4.9 x 10<sup>−5</sup>) and between wt mc-<italic>IRA2</italic> and <italic>pde2Δ</italic> mc-<italic>IRA2</italic> strains (n = 21 and 6, respectively, p=3.5×10<sup>−7</sup>). F) Doubling times of control and mc-<italic>IRA2</italic> strains are significantly different for the wt control (n = 3 each, p=0.00042), the wt o/e <italic>PDE2</italic> (n = 3 each, p=0.00091) and for the <italic>tsa1Δ</italic> mc-<italic>PDE2</italic> strain (n = 3, p=0.0058) but not for the <italic>tsa1Δ</italic> control strain (n = 3 each, p=0.20). G) The time Msn2 spent in the nucleus is significantly different in the wt vector control (n = 82) vs. <italic>mc-BCY1</italic> (n = 76, p&lt;0.001) but not <italic>tsa1Δ</italic> vector control (n = 46) vs. <italic>mc-BCY1</italic> (n = 74, p=0.14). H) Relative Ras2-GTP/total Ras values in the control and mc-<italic>IRA2</italic> are significantly different in a two tailed t-test with unequal variance for the wt (n = 3, p=0.0041). Values for the <italic>pde2Δ</italic> control vs mc-<italic>IRA2</italic> (n = 3, p=0.015) and the <italic>tsa1Δ</italic> control vs mc-<italic>IRA2</italic> (n = 3, p=0.030) are significantly different in a two-tailed t-test with equal variance. I) cAMP levels are significantly different only between wt and <italic>pde2Δ</italic> strains (n = 4 each, wt yEP24 vs pde2 yEP24, p=0.0050 and wt pKF56 vs pde2 pKF56, p=1.4×10<sup>−5</sup>). No significant differences were seen between wt and <italic>tsa1Δ</italic> strains (n = 4 each, wt yEP24 vs <italic>tsa1Δ</italic> yEP24, p=0.86 and wt pKF56 vs <italic>tsa1Δ</italic> pKF56 p=0.47) or between the wt yEP24 and wt pKF56 (p=0.13).</p><p><xref ref-type="fig" rid="fig3">Figure 3</xref> (A) Lifespans of the wt (n = 168) vs the <italic>tsa1Δ</italic> mutant (n = 293), wt vs <italic>tsa1C48S</italic> (n = 70), wt vs <italic>tsa1C171S</italic> (n = 120), <italic>tsa1ΔYF</italic> (n = 255) vs <italic>tsa1ΔYFC171S</italic> (n = 70) are all different at p&lt;0.00001. The lifespan of the <italic>tsa1ΔYF</italic> mutant is different from the wt at p&lt;0.00854 whereas no significant difference was seen between the <italic>tsa1Δ</italic> vs <italic>tsa1C48S</italic> (p=0.11), <italic>tsa1C48S</italic> vs <italic>tsa1C171S</italic> (p=0.31), <italic>tsa1ΔYFC171S</italic> vs <italic>tsa1C171S</italic> (p=0.23). C. H<sub>2</sub>O<sub>2</sub> resistance is significantly different between wt and <italic>ras2Δ</italic> strains (p=0.013), wt and <italic>tsa1Δ</italic> (p=0.0049) and <italic>tsa1Δ</italic> and <italic>ras2Δ tsa1Δ</italic> (p=0.010). D. H<sub>2</sub>O<sub>2</sub> resistance is significantly different between wt control and o/e <italic>TSA1</italic> strains (p=0.0085), between wt o/e <italic>TSA1</italic> and <italic>pde2Δ</italic> o/e <italic>TSA1</italic> strains (p=0.0082) but not between <italic>pde2Δ</italic> control and o/e <italic>TSA1</italic> strains (p=0.56). E. H<sub>2</sub>O<sub>2</sub> resistance is significantly different between wt vector and mc-<italic>IRA2</italic> strains (p=0.016), wt vector and <italic>tsa1Δ</italic> vector strains (p=0.049), <italic>tsa1Δ</italic> vector and mc-<italic>IRA2</italic> strains (p=0.00056), <italic>tsa1Δ</italic> mc-<italic>IRA2</italic> and <italic>pde2Δtsa1Δ</italic> mc-<italic>IRA2</italic> strains (p=0.0025) but neither the <italic>pde2Δ</italic> vector and mc-<italic>IRA2</italic> strains (p=0.40) nor <italic>trx1Δ trx2Δ</italic> vector and <italic>trx1Δtrx2Δ</italic> mc-<italic>IRA2</italic> strains (p=0.24). F. The scavenging rates of the wt and the <italic>tsa1Δ</italic> mutant following the addition of 0.4 mM are not significant in a two-tailed t-test assuming equal variance (p=0.684). G. Fluorescence ratios 500/420 nm of the HyPer3 expressing strains are significantly different between the wt young (n = 231) vs old (n = 319) (p=2.42×10<sup>−13</sup>) and wt young vs wt young +H<sub>2</sub>O<sub>2</sub> (n = 202) (p=5.27×10<sup>−76</sup>) but not when comparing wt old vs <italic>tsa1Δ</italic> old (n = 236)(p=0.101). H. Fluorescence ratios 500/420 nm of the HyPer3 expressing strains are neither significantly different between the wt young (n = 404) vs the o/e <italic>TSA1</italic> young (n = 579, p=0.069) nor the wt old (n = 190) vs o/e <italic>TSA1</italic> old (n = 204, p=0.755).</p><p><xref ref-type="fig" rid="fig4">Figure 4</xref> (C) The abundances of all the three T241-phosphorylated peptides decreased significantly upon adding either 0.4 mM or 0.8 mM H2O2 (for the C243-SH peptide p=0.05 and 0.037 respectively, for the C243-SSG peptide p=0.015 and 0.025 respectively whereas for the C243-SO<sub>3</sub>H peptide p=0.011 and 0.0049, respectively. The quantity of the C243-SH T241 non-modified peptide did not change significantly upon the addition of 0.4 and 0.8 mM H<sub>2</sub>O<sub>2</sub> (p=0.20 and 0.54, respectively) whereas the C243-SSG T241 non-modified peptide increased significantly following 0.4 mM (p=0.038) but not at 0.8 mM (p=0.17). F. Tpk1-S-SG levels are significantly different between wt with and without H<sub>2</sub>O<sub>2</sub> (p=0.012), but not between wt and <italic>tsa1Δ</italic> without H<sub>2</sub>O<sub>2</sub> (p=0.453) or in the <italic>tsa1Δ</italic> with and without H<sub>2</sub>O<sub>2</sub> (p=0.264).</p><p><xref ref-type="fig" rid="fig5">Figure 5</xref> (A) H<sub>2</sub>O<sub>2</sub> resistance is significantly different between wt pRS313 vector control and <italic>tpk2Δtpk3Δ</italic> pRS313 vector control strains (p=0.030), <italic>tpk1Δtpk2Δtpk3Δ pTPK1</italic> and <italic>ptpk1C243A</italic>strains (p=0.030), <italic>tpk1Δtpk2Δtpk3Δ pTPK1</italic> and <italic>ptpk1T241A</italic> strains (p=0.0020) but not <italic>tpk2Δtpk3Δ</italic> pRS313 and <italic>tpk1Δtpk2Δtpk3Δ pTPK1</italic> strains (p=1.00). (B) H<sub>2</sub>O<sub>2</sub> resistance is significantly different between control <italic>pTPK1</italic> and <italic>ptpk1C243A</italic> strains (p=0.043), control <italic>pTPK1</italic> and <italic>pTSA1 pTPK1</italic> strains (p=0.0072), <italic>pTSA1 pTPK1</italic> and <italic>ptpk1C243A</italic> strains (p=0.0014) but not between control <italic>ptpk1C243A</italic> and <italic>pTSA1 ptpk1C243A</italic> strains (p=0.064). (C) H<sub>2</sub>O<sub>2</sub> resistance is significantly different between <italic>TSA1 pTPK1</italic> and <italic>ptpk1T241A</italic> strains (p=0.022), <italic>TSA1 pTPK1</italic> and <italic>tsa1Δ pTPK1</italic> strains (p=0.031), <italic>tsa1Δ pTPK1</italic> and <italic>ptpk1T241A</italic> strains (p=0.013) but not between <italic>TSA1</italic> and <italic>tsa1Δ ptpk1T241A</italic> strains (p=0.090).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We are grateful to Karin Voordeckers, Joseph Heitman and Robert J Deschenes for reagents and Mattias Johansson and Lainy Ramirez for technical assistance.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation</p></fn><fn fn-type="con" id="con3"><p>Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Investigation</p></fn><fn fn-type="con" id="con7"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con8"><p>Investigation</p></fn><fn fn-type="con" id="con9"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Methodology</p></fn><fn fn-type="con" id="con11"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con12"><p>Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con13"><p>Methodology</p></fn><fn fn-type="con" id="con14"><p>Writing - review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Mass spectrometry data.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-60346-supp1-v3.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-60346-transrepform-v3.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Proteomics data have been deposited in the PRIDE repository.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Roger</surname><given-names>F</given-names></name><name><surname>Picazo</surname><given-names>C</given-names></name><name><surname>Reiter</surname><given-names>W</given-names></name><name><surname>Libiad</surname><given-names>M</given-names></name><name><surname>Asami</surname><given-names>C</given-names></name><name><surname>Hanzén</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>C</given-names></name><name><surname>Lagniel</surname><given-names>G</given-names></name><name><surname>Welkenhuysen</surname><given-names>N</given-names></name><name><surname>Labarre</surname><given-names>J</given-names></name><name><surname>Nyström</surname><given-names>T</given-names></name><name><surname>Grøtli</surname><given-names>M</given-names></name><name><surname>Hartl</surname><given-names>M</given-names></name><name><surname>Toledano</surname><given-names>M</given-names></name><name><surname>Molin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Peroxiredoxin promotes longevity and H2O2-resistance in yeast through redox modulation of protein kinase A</data-title><source>PRIDE</source><pub-id assigning-authority="EBI" pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD012617">PXD012617</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>MJ</given-names></name><name><surname>Murtola</surname> <given-names>T</given-names></name><name><surname>Schulz</surname> <given-names>R</given-names></name><name><surname>Páll</surname> <given-names>S</given-names></name><name><surname>Smith</surname> <given-names>JC</given-names></name><name><surname>Hess</surname> <given-names>B</given-names></name><name><surname>Lindahl</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers</article-title><source>SoftwareX</source><volume>1-2</volume><fpage>19</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.softx.2015.06.001</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alic</surname> <given-names>N</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Death and dessert: nutrient signalling pathways and ageing</article-title><source>Current Opinion in Cell Biology</source><volume>23</volume><fpage>738</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2011.07.006</pub-id><pub-id pub-id-type="pmid">21835601</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendsen</surname> <given-names>HJC</given-names></name><name><surname>Postma</surname> <given-names>JPM</given-names></name><name><surname>van Gunsteren</surname> <given-names>WF</given-names></name><name><surname>DiNola</surname> <given-names>A</given-names></name><name><surname>Haak</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Molecular dynamics with coupling to an external bath</article-title><source>The Journal of Chemical Physics</source><volume>81</volume><fpage>3684</fpage><lpage>3690</lpage><pub-id pub-id-type="doi">10.1063/1.448118</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilan</surname> <given-names>DS</given-names></name><name><surname>Pase</surname> <given-names>L</given-names></name><name><surname>Joosen</surname> <given-names>L</given-names></name><name><surname>Gorokhovatsky</surname> <given-names>AY</given-names></name><name><surname>Ermakova</surname> <given-names>YG</given-names></name><name><surname>Gadella</surname> <given-names>TWJ</given-names></name><name><surname>Grabher</surname> <given-names>C</given-names></name><name><surname>Schultz</surname> <given-names>C</given-names></name><name><surname>Lukyanov</surname> <given-names>S</given-names></name><name><surname>Belousov</surname> <given-names>VV</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>HyPer-3: A Genetically Encoded H<sub>2</sub>O<sub>2</sub> Probe with Improved Performance for Ratiometric and Fluorescence Lifetime Imaging</article-title><source>ACS Chemical Biology</source><volume>8</volume><fpage>535</fpage><lpage>542</lpage><pub-id pub-id-type="doi">10.1021/cb300625g</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biteau</surname> <given-names>B</given-names></name><name><surname>Labarre</surname> <given-names>J</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>ATP-dependent reduction of cysteine-sulphinic acid by <italic>S. cerevisiae</italic> sulphiredoxin</article-title><source>Nature</source><volume>425</volume><fpage>980</fpage><lpage>984</lpage><pub-id pub-id-type="doi">10.1038/nature02075</pub-id><pub-id pub-id-type="pmid">14586471</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bodvard</surname> <given-names>K</given-names></name><name><surname>Peeters</surname> <given-names>K</given-names></name><name><surname>Roger</surname> <given-names>F</given-names></name><name><surname>Romanov</surname> <given-names>N</given-names></name><name><surname>Igbaria</surname> <given-names>A</given-names></name><name><surname>Welkenhuysen</surname> <given-names>N</given-names></name><name><surname>Palais</surname> <given-names>G</given-names></name><name><surname>Reiter</surname> <given-names>W</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name><name><surname>Käll</surname> <given-names>M</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Light-sensing via hydrogen peroxide and a peroxiredoxin</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14791</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14791</pub-id><pub-id pub-id-type="pmid">28337980</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broach</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nutritional control of growth and development in yeast</article-title><source>Genetics</source><volume>192</volume><fpage>73</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.135731</pub-id><pub-id pub-id-type="pmid">22964838</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgoyne</surname> <given-names>JR</given-names></name><name><surname>Madhani</surname> <given-names>M</given-names></name><name><surname>Cuello</surname> <given-names>F</given-names></name><name><surname>Charles</surname> <given-names>RL</given-names></name><name><surname>Brennan</surname> <given-names>JP</given-names></name><name><surname>Schröder</surname> <given-names>E</given-names></name><name><surname>Browning</surname> <given-names>DD</given-names></name><name><surname>Eaton</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cysteine redox sensor in PKGIa enables oxidant-induced activation</article-title><source>Science</source><volume>317</volume><fpage>1393</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.1126/science.1144318</pub-id><pub-id pub-id-type="pmid">17717153</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgoyne</surname> <given-names>JR</given-names></name><name><surname>Rudyk</surname> <given-names>O</given-names></name><name><surname>Cho</surname> <given-names>HJ</given-names></name><name><surname>Prysyazhna</surname> <given-names>O</given-names></name><name><surname>Hathaway</surname> <given-names>N</given-names></name><name><surname>Weeks</surname> <given-names>A</given-names></name><name><surname>Evans</surname> <given-names>R</given-names></name><name><surname>Ng</surname> <given-names>T</given-names></name><name><surname>Schröder</surname> <given-names>K</given-names></name><name><surname>Brandes</surname> <given-names>RP</given-names></name><name><surname>Shah</surname> <given-names>AM</given-names></name><name><surname>Eaton</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Deficient angiogenesis in redox-dead Cys17Ser pkariα knock-in mice</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7920</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8920</pub-id><pub-id pub-id-type="pmid">26258640</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caballero</surname> <given-names>A</given-names></name><name><surname>Ugidos</surname> <given-names>A</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Öling</surname> <given-names>D</given-names></name><name><surname>Kvint</surname> <given-names>K</given-names></name><name><surname>Hao</surname> <given-names>X</given-names></name><name><surname>Mignat</surname> <given-names>C</given-names></name><name><surname>Nachin</surname> <given-names>L</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Nyström</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Absence of mitochondrial translation control proteins extends life span by activating sirtuin-dependent silencing</article-title><source>Molecular Cell</source><volume>42</volume><fpage>390</fpage><lpage>400</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.03.021</pub-id><pub-id pub-id-type="pmid">21549315</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname> <given-names>S</given-names></name><name><surname>Martegani</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Methods to study the Ras2 protein activation state and the subcellular localization of Ras-GTP in <italic>Saccharomyces cerevisiae</italic></article-title><source>Methods in Molecular Biology</source><volume>1120</volume><fpage>391</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-791-4_24</pub-id><pub-id pub-id-type="pmid">24470038</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costanzo</surname> <given-names>M</given-names></name><name><surname>Baryshnikova</surname> <given-names>A</given-names></name><name><surname>Bellay</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Spear</surname> <given-names>ED</given-names></name><name><surname>Sevier</surname> <given-names>CS</given-names></name><name><surname>Ding</surname> <given-names>H</given-names></name><name><surname>Koh</surname> <given-names>JL</given-names></name><name><surname>Toufighi</surname> <given-names>K</given-names></name><name><surname>Mostafavi</surname> <given-names>S</given-names></name><name><surname>Prinz</surname> <given-names>J</given-names></name><name><surname>St Onge</surname> <given-names>RP</given-names></name><name><surname>VanderSluis</surname> <given-names>B</given-names></name><name><surname>Makhnevych</surname> <given-names>T</given-names></name><name><surname>Vizeacoumar</surname> <given-names>FJ</given-names></name><name><surname>Alizadeh</surname> <given-names>S</given-names></name><name><surname>Bahr</surname> <given-names>S</given-names></name><name><surname>Brost</surname> <given-names>RL</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Cokol</surname> <given-names>M</given-names></name><name><surname>Deshpande</surname> <given-names>R</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Lin</surname> <given-names>ZY</given-names></name><name><surname>Liang</surname> <given-names>W</given-names></name><name><surname>Marback</surname> <given-names>M</given-names></name><name><surname>Paw</surname> <given-names>J</given-names></name><name><surname>San Luis</surname> <given-names>BJ</given-names></name><name><surname>Shuteriqi</surname> <given-names>E</given-names></name><name><surname>Tong</surname> <given-names>AH</given-names></name><name><surname>van Dyk</surname> <given-names>N</given-names></name><name><surname>Wallace</surname> <given-names>IM</given-names></name><name><surname>Whitney</surname> <given-names>JA</given-names></name><name><surname>Weirauch</surname> <given-names>MT</given-names></name><name><surname>Zhong</surname> <given-names>G</given-names></name><name><surname>Zhu</surname> <given-names>H</given-names></name><name><surname>Houry</surname> <given-names>WA</given-names></name><name><surname>Brudno</surname> <given-names>M</given-names></name><name><surname>Ragibizadeh</surname> <given-names>S</given-names></name><name><surname>Papp</surname> <given-names>B</given-names></name><name><surname>Pál</surname> <given-names>C</given-names></name><name><surname>Roth</surname> <given-names>FP</given-names></name><name><surname>Giaever</surname> <given-names>G</given-names></name><name><surname>Nislow</surname> <given-names>C</given-names></name><name><surname>Troyanskaya</surname> <given-names>OG</given-names></name><name><surname>Bussey</surname> <given-names>H</given-names></name><name><surname>Bader</surname> <given-names>GD</given-names></name><name><surname>Gingras</surname> <given-names>AC</given-names></name><name><surname>Morris</surname> <given-names>QD</given-names></name><name><surname>Kim</surname> <given-names>PM</given-names></name><name><surname>Kaiser</surname> <given-names>CA</given-names></name><name><surname>Myers</surname> <given-names>CL</given-names></name><name><surname>Andrews</surname> <given-names>BJ</given-names></name><name><surname>Boone</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The genetic landscape of a cell</article-title><source>Science</source><volume>327</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1126/science.1180823</pub-id><pub-id pub-id-type="pmid">20093466</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darden</surname> <given-names>T</given-names></name><name><surname>York</surname> <given-names>D</given-names></name><name><surname>Pedersen</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Particle mesh Ewald - an n.log(N) Method for Ewald sums in large systems</article-title><source>Journal of Chemical Physics</source><volume>98</volume><fpage>10089 </fpage><lpage>1010092</lpage><pub-id pub-id-type="doi">10.1063/1.464397</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Haes</surname> <given-names>W</given-names></name><name><surname>Frooninckx</surname> <given-names>L</given-names></name><name><surname>Van Assche</surname> <given-names>R</given-names></name><name><surname>Smolders</surname> <given-names>A</given-names></name><name><surname>Depuydt</surname> <given-names>G</given-names></name><name><surname>Billen</surname> <given-names>J</given-names></name><name><surname>Braeckman</surname> <given-names>BP</given-names></name><name><surname>Schoofs</surname> <given-names>L</given-names></name><name><surname>Temmerman</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2</article-title><source>PNAS</source><volume>111</volume><fpage>E2501</fpage><lpage>E2509</lpage><pub-id pub-id-type="doi">10.1073/pnas.1321776111</pub-id><pub-id pub-id-type="pmid">24889636</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Piña</surname> <given-names>MZ</given-names></name><name><surname>Vázquez-Meza</surname> <given-names>H</given-names></name><name><surname>Pardo</surname> <given-names>JP</given-names></name><name><surname>Rendón</surname> <given-names>JL</given-names></name><name><surname>Villalobos-Molina</surname> <given-names>R</given-names></name><name><surname>Riveros-Rosas</surname> <given-names>H</given-names></name><name><surname>Piña</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Signaling the signal, cyclic AMP-dependent protein kinase inhibition by insulin-formed H2O2 and reactivation by thioredoxin</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>12373</fpage><lpage>12386</lpage><pub-id pub-id-type="doi">10.1074/jbc.M706832200</pub-id><pub-id pub-id-type="pmid">18326045</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deprez</surname> <given-names>MA</given-names></name><name><surname>Eskes</surname> <given-names>E</given-names></name><name><surname>Wilms</surname> <given-names>T</given-names></name><name><surname>Ludovico</surname> <given-names>P</given-names></name><name><surname>Winderickx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>pH homeostasis links the nutrient sensing PKA/TORC1/Sch9 ménage-à-trois to stress tolerance and longevity</article-title><source>Microbial Cell</source><volume>5</volume><fpage>119</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.15698/mic2018.03.618</pub-id><pub-id pub-id-type="pmid">29487859</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depry</surname> <given-names>C</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Using FRET-based reporters to visualize subcellular dynamics of protein kinase A activity</article-title><source>Methods in Molecular Biology</source><volume>756</volume><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1007/978-1-61779-160-4_16</pub-id><pub-id pub-id-type="pmid">21870233</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dillin</surname> <given-names>A</given-names></name><name><surname>Gottschling</surname> <given-names>DE</given-names></name><name><surname>Nyström</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The good and the bad of being connected: the integrons of aging</article-title><source>Current Opinion in Cell Biology</source><volume>26</volume><fpage>107</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2013.12.003</pub-id><pub-id pub-id-type="pmid">24529252</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erjavec</surname> <given-names>N</given-names></name><name><surname>Larsson</surname> <given-names>L</given-names></name><name><surname>Grantham</surname> <given-names>J</given-names></name><name><surname>Nystrom</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Accelerated aging and failure to segregate damaged proteins in Sir2 mutants can be suppressed by overproducing the protein aggregation-remodeling factor Hsp104p</article-title><source>Genes and Development</source><volume>21</volume><fpage>2410</fpage><lpage>2421</lpage><pub-id pub-id-type="doi">10.1101/gad.439307</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essmann</surname> <given-names>U</given-names></name><name><surname>Perera</surname> <given-names>L</given-names></name><name><surname>Berkowitz</surname> <given-names>ML</given-names></name><name><surname>Darden</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>H</given-names></name><name><surname>Pedersen</surname> <given-names>LG</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A smooth particle mesh ewald method</article-title><source>The Journal of Chemical Physics</source><volume>103</volume><fpage>8577</fpage><lpage>8593</lpage><pub-id pub-id-type="doi">10.1063/1.470117</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filteau</surname> <given-names>M</given-names></name><name><surname>Diss</surname> <given-names>G</given-names></name><name><surname>Torres-Quiroz</surname> <given-names>F</given-names></name><name><surname>Dubé</surname> <given-names>AK</given-names></name><name><surname>Schraffl</surname> <given-names>A</given-names></name><name><surname>Bachmann</surname> <given-names>VA</given-names></name><name><surname>Gagnon-Arsenault</surname> <given-names>I</given-names></name><name><surname>Chrétien</surname> <given-names>AÈ</given-names></name><name><surname>Steunou</surname> <given-names>AL</given-names></name><name><surname>Dionne</surname> <given-names>U</given-names></name><name><surname>Côté</surname> <given-names>J</given-names></name><name><surname>Bisson</surname> <given-names>N</given-names></name><name><surname>Stefan</surname> <given-names>E</given-names></name><name><surname>Landry</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Systematic identification of signal integration by protein kinase A</article-title><source>PNAS</source><volume>112</volume><fpage>4501</fpage><lpage>4506</lpage><pub-id pub-id-type="doi">10.1073/pnas.1409938112</pub-id><pub-id pub-id-type="pmid">25831502</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontán-Lozano</surname> <given-names>A</given-names></name><name><surname>López-Lluch</surname> <given-names>G</given-names></name><name><surname>Delgado-García</surname> <given-names>JM</given-names></name><name><surname>Navas</surname> <given-names>P</given-names></name><name><surname>Carrión</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Molecular bases of caloric restriction regulation of neuronal synaptic plasticity</article-title><source>Molecular Neurobiology</source><volume>38</volume><fpage>167</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1007/s12035-008-8040-1</pub-id><pub-id pub-id-type="pmid">18759009</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname> <given-names>L</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Longo</surname> <given-names>VD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Extending healthy life span--from yeast to humans</article-title><source>Science</source><volume>328</volume><fpage>321</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1126/science.1172539</pub-id><pub-id pub-id-type="pmid">20395504</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garrett</surname> <given-names>S</given-names></name><name><surname>Broach</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Loss of ras activity in <italic>Saccharomyces cerevisiae</italic> is suppressed by disruptions of a new kinase gene, YAKI, whose product may act downstream of the cAMP-dependent protein kinase</article-title><source>Genes &amp; Development</source><volume>3</volume><fpage>1336</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1101/gad.3.9.1336</pub-id><pub-id pub-id-type="pmid">2558053</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giaever</surname> <given-names>G</given-names></name><name><surname>Chu</surname> <given-names>AM</given-names></name><name><surname>Ni</surname> <given-names>L</given-names></name><name><surname>Connelly</surname> <given-names>C</given-names></name><name><surname>Riles</surname> <given-names>L</given-names></name><name><surname>Véronneau</surname> <given-names>S</given-names></name><name><surname>Dow</surname> <given-names>S</given-names></name><name><surname>Lucau-Danila</surname> <given-names>A</given-names></name><name><surname>Anderson</surname> <given-names>K</given-names></name><name><surname>André</surname> <given-names>B</given-names></name><name><surname>Arkin</surname> <given-names>AP</given-names></name><name><surname>Astromoff</surname> <given-names>A</given-names></name><name><surname>El Bakkoury</surname> <given-names>M</given-names></name><name><surname>Bangham</surname> <given-names>R</given-names></name><name><surname>Benito</surname> <given-names>R</given-names></name><name><surname>Brachat</surname> <given-names>S</given-names></name><name><surname>Campanaro</surname> <given-names>S</given-names></name><name><surname>Curtiss</surname> <given-names>M</given-names></name><name><surname>Davis</surname> <given-names>K</given-names></name><name><surname>Deutschbauer</surname> <given-names>A</given-names></name><name><surname>Entian</surname> <given-names>K-D</given-names></name><name><surname>Flaherty</surname> <given-names>P</given-names></name><name><surname>Foury</surname> <given-names>F</given-names></name><name><surname>Garfinkel</surname> <given-names>DJ</given-names></name><name><surname>Gerstein</surname> <given-names>M</given-names></name><name><surname>Gotte</surname> <given-names>D</given-names></name><name><surname>Güldener</surname> <given-names>U</given-names></name><name><surname>Hegemann</surname> <given-names>JH</given-names></name><name><surname>Hempel</surname> <given-names>S</given-names></name><name><surname>Herman</surname> <given-names>Z</given-names></name><name><surname>Jaramillo</surname> <given-names>DF</given-names></name><name><surname>Kelly</surname> <given-names>DE</given-names></name><name><surname>Kelly</surname> <given-names>SL</given-names></name><name><surname>Kötter</surname> <given-names>P</given-names></name><name><surname>LaBonte</surname> <given-names>D</given-names></name><name><surname>Lamb</surname> <given-names>DC</given-names></name><name><surname>Lan</surname> <given-names>N</given-names></name><name><surname>Liang</surname> <given-names>H</given-names></name><name><surname>Liao</surname> <given-names>H</given-names></name><name><surname>Liu</surname> <given-names>L</given-names></name><name><surname>Luo</surname> <given-names>C</given-names></name><name><surname>Lussier</surname> <given-names>M</given-names></name><name><surname>Mao</surname> <given-names>R</given-names></name><name><surname>Menard</surname> <given-names>P</given-names></name><name><surname>Ooi</surname> <given-names>SL</given-names></name><name><surname>Revuelta</surname> <given-names>JL</given-names></name><name><surname>Roberts</surname> <given-names>CJ</given-names></name><name><surname>Rose</surname> <given-names>M</given-names></name><name><surname>Ross-Macdonald</surname> <given-names>P</given-names></name><name><surname>Scherens</surname> <given-names>B</given-names></name><name><surname>Schimmack</surname> <given-names>G</given-names></name><name><surname>Shafer</surname> <given-names>B</given-names></name><name><surname>Shoemaker</surname> <given-names>DD</given-names></name><name><surname>Sookhai-Mahadeo</surname> <given-names>S</given-names></name><name><surname>Storms</surname> <given-names>RK</given-names></name><name><surname>Strathern</surname> <given-names>JN</given-names></name><name><surname>Valle</surname> <given-names>G</given-names></name><name><surname>Voet</surname> <given-names>M</given-names></name><name><surname>Volckaert</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>C-Y</given-names></name><name><surname>Ward</surname> <given-names>TR</given-names></name><name><surname>Wilhelmy</surname> <given-names>J</given-names></name><name><surname>Winzeler</surname> <given-names>EA</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Yen</surname> <given-names>G</given-names></name><name><surname>Youngman</surname> <given-names>E</given-names></name><name><surname>Yu</surname> <given-names>K</given-names></name><name><surname>Bussey</surname> <given-names>H</given-names></name><name><surname>Boeke</surname> <given-names>JD</given-names></name><name><surname>Snyder</surname> <given-names>M</given-names></name><name><surname>Philippsen</surname> <given-names>P</given-names></name><name><surname>Davis</surname> <given-names>RW</given-names></name><name><surname>Johnston</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Functional profiling of the <italic>Saccharomyces cerevisiae</italic> genome</article-title><source>Nature</source><volume>418</volume><fpage>387</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/nature00935</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname> <given-names>AL</given-names></name><name><surname>McCusker</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Three new dominant drug resistance cassettes for gene disruption <italic>in Saccharomyces cerevisiae</italic></article-title><source>Yeast</source><volume>15</volume><fpage>1541</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0061(199910)15:14&lt;1541::AID-YEA476&gt;3.0.CO;2-K</pub-id><pub-id pub-id-type="pmid">10514571</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goulev</surname> <given-names>Y</given-names></name><name><surname>Morlot</surname> <given-names>S</given-names></name><name><surname>Matifas</surname> <given-names>A</given-names></name><name><surname>Huang</surname> <given-names>B</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name><name><surname>Charvin</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Nonlinear feedback drives homeostatic plasticity in H2O2 stress response</article-title><source>eLife</source><volume>6</volume><elocation-id>23791</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.23971</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gueldener</surname> <given-names>U</given-names></name><name><surname>Heinisch</surname> <given-names>J</given-names></name><name><surname>Koehler</surname> <given-names>GJ</given-names></name><name><surname>Voss</surname> <given-names>D</given-names></name><name><surname>Hegemann</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A second set of loxP marker cassettes for Cre-mediated multiple gene knockouts in budding yeast</article-title><source>Nucleic Acids Research</source><volume>30</volume><elocation-id>e23</elocation-id><pub-id pub-id-type="doi">10.1093/nar/30.6.e23</pub-id><pub-id pub-id-type="pmid">11884642</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanzén</surname> <given-names>S</given-names></name><name><surname>Vielfort</surname> <given-names>K</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Roger</surname> <given-names>F</given-names></name><name><surname>Andersson</surname> <given-names>V</given-names></name><name><surname>Zamarbide-Forés</surname> <given-names>S</given-names></name><name><surname>Andersson</surname> <given-names>R</given-names></name><name><surname>Malm</surname> <given-names>L</given-names></name><name><surname>Palais</surname> <given-names>G</given-names></name><name><surname>Biteau</surname> <given-names>B</given-names></name><name><surname>Liu</surname> <given-names>B</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Nyström</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lifespan control by Redox-Dependent recruitment of chaperones to misfolded proteins</article-title><source>Cell</source><volume>166</volume><fpage>140</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.05.006</pub-id><pub-id pub-id-type="pmid">27264606</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasan</surname> <given-names>R</given-names></name><name><surname>Leroy</surname> <given-names>C</given-names></name><name><surname>Isnard</surname> <given-names>AD</given-names></name><name><surname>Labarre</surname> <given-names>J</given-names></name><name><surname>Boy-Marcotte</surname> <given-names>E</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The control of the yeast H2O2 response by the Msn2/4 transcription factors</article-title><source>Molecular Microbiology</source><volume>45</volume><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.2002.03011.x</pub-id><pub-id pub-id-type="pmid">12100562</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heilbronn</surname> <given-names>LK</given-names></name><name><surname>de Jonge</surname> <given-names>L</given-names></name><name><surname>Frisard</surname> <given-names>MI</given-names></name><name><surname>DeLany</surname> <given-names>JP</given-names></name><name><surname>Larson-Meyer</surname> <given-names>DE</given-names></name><name><surname>Rood</surname> <given-names>J</given-names></name><name><surname>Nguyen</surname> <given-names>T</given-names></name><name><surname>Martin</surname> <given-names>CK</given-names></name><name><surname>Volaufova</surname> <given-names>J</given-names></name><name><surname>Most</surname> <given-names>MM</given-names></name><name><surname>Greenway</surname> <given-names>FL</given-names></name><name><surname>Smith</surname> <given-names>SR</given-names></name><name><surname>Deutsch</surname> <given-names>WA</given-names></name><name><surname>Williamson</surname> <given-names>DA</given-names></name><name><surname>Ravussin</surname> <given-names>E</given-names></name><collab>Pennington CALERIE Team</collab></person-group><year iso-8601-date="2006">2006</year><article-title>Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial</article-title><source>Jama</source><volume>295</volume><fpage>1539</fpage><lpage>1548</lpage><pub-id pub-id-type="doi">10.1001/jama.295.13.1539</pub-id><pub-id pub-id-type="pmid">16595757</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hess</surname> <given-names>B</given-names></name><name><surname>Bekker</surname> <given-names>H</given-names></name><name><surname>Berendsen</surname> <given-names>HJC</given-names></name><name><surname>Fraaije</surname> <given-names>JGEM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>LINCS: a linear constraint solver for molecular simulations</article-title><source>Journal of Computational Chemistry</source><volume>18</volume><fpage>1463</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(199709)18:12&lt;1463::AID-JCC4&gt;3.0.CO;2-H</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoover</surname> <given-names>WG</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Canonical dynamics: equilibrium phase-space distributions</article-title><source>Physical Review A</source><volume>31</volume><fpage>1695</fpage><lpage>1697</lpage><pub-id pub-id-type="doi">10.1103/PhysRevA.31.1695</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hourihan</surname> <given-names>JM</given-names></name><name><surname>Moronetti Mazzeo</surname> <given-names>LE</given-names></name><name><surname>Fernández-Cárdenas</surname> <given-names>LP</given-names></name><name><surname>Blackwell</surname> <given-names>TK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cysteine sulfenylation directs IRE-1 to activate the SKN-1/Nrf2 antioxidant response</article-title><source>Molecular Cell</source><volume>63</volume><fpage>553</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.07.019</pub-id><pub-id pub-id-type="pmid">27540856</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname> <given-names>KM</given-names></name><name><surname>Juliano</surname> <given-names>C</given-names></name><name><surname>Taylor</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Regulation of cAMP-dependent protein kinase activity by glutathionylation</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>43505</fpage><lpage>43511</lpage><pub-id pub-id-type="doi">10.1074/jbc.M207088200</pub-id><pub-id pub-id-type="pmid">12189155</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphries</surname> <given-names>KM</given-names></name><name><surname>Deal</surname> <given-names>MS</given-names></name><name><surname>Taylor</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification</article-title><source>Journal of Biological Chemistry</source><volume>280</volume><fpage>2750</fpage><lpage>2758</lpage><pub-id pub-id-type="doi">10.1074/jbc.M410242200</pub-id><pub-id pub-id-type="pmid">15533936</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobson</surname> <given-names>MP</given-names></name><name><surname>Friesner</surname> <given-names>RA</given-names></name><name><surname>Xiang</surname> <given-names>Z</given-names></name><name><surname>Honig</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>On the role of the crystal environment in determining protein side-chain conformations</article-title><source>Journal of Molecular Biology</source><volume>320</volume><fpage>597</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(02)00470-9</pub-id><pub-id pub-id-type="pmid">12096912</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname> <given-names>HH</given-names></name><name><surname>Lee</surname> <given-names>KO</given-names></name><name><surname>Chi</surname> <given-names>YH</given-names></name><name><surname>Jung</surname> <given-names>BG</given-names></name><name><surname>Park</surname> <given-names>SK</given-names></name><name><surname>Park</surname> <given-names>JH</given-names></name><name><surname>Lee</surname> <given-names>JR</given-names></name><name><surname>Lee</surname> <given-names>SS</given-names></name><name><surname>Moon</surname> <given-names>JC</given-names></name><name><surname>Yun</surname> <given-names>JW</given-names></name><name><surname>Choi</surname> <given-names>YO</given-names></name><name><surname>Kim</surname> <given-names>WY</given-names></name><name><surname>Kang</surname> <given-names>JS</given-names></name><name><surname>Cheong</surname> <given-names>GW</given-names></name><name><surname>Yun</surname> <given-names>DJ</given-names></name><name><surname>Rhee</surname> <given-names>SG</given-names></name><name><surname>Cho</surname> <given-names>MJ</given-names></name><name><surname>Lee</surname> <given-names>SY</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function</article-title><source>Cell</source><volume>117</volume><fpage>625</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2004.05.002</pub-id><pub-id pub-id-type="pmid">15163410</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenyon</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The genetics of ageing</article-title><source>Nature</source><volume>464</volume><fpage>504</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/nature08980</pub-id><pub-id pub-id-type="pmid">20336132</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klaus</surname> <given-names>A</given-names></name><name><surname>Zorman</surname> <given-names>S</given-names></name><name><surname>Berthier</surname> <given-names>A</given-names></name><name><surname>Polge</surname> <given-names>C</given-names></name><name><surname>Ramirez</surname> <given-names>S</given-names></name><name><surname>Michelland</surname> <given-names>S</given-names></name><name><surname>Sève</surname> <given-names>M</given-names></name><name><surname>Vertommen</surname> <given-names>D</given-names></name><name><surname>Rider</surname> <given-names>M</given-names></name><name><surname>Lentze</surname> <given-names>N</given-names></name><name><surname>Auerbach</surname> <given-names>D</given-names></name><name><surname>Schlattner</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Glutathione S-transferases interact with AMP-activated protein kinase: evidence for S-glutathionylation and activation in vitro</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e62497</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0062497</pub-id><pub-id pub-id-type="pmid">23741294</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname> <given-names>AT</given-names></name><name><surname>Leprevost</surname> <given-names>FV</given-names></name><name><surname>Avtonomov</surname> <given-names>DM</given-names></name><name><surname>Mellacheruvu</surname> <given-names>D</given-names></name><name><surname>Nesvizhskii</surname> <given-names>AI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics</article-title><source>Nature Methods</source><volume>14</volume><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4256</pub-id><pub-id pub-id-type="pmid">28394336</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lamming</surname> <given-names>DW</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2014">2014</year><source>Metabolic Effects of Caloric Restriction</source><publisher-name>John Wiley Sons</publisher-name></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>KS</given-names></name><name><surname>Iijima-Ando</surname> <given-names>K</given-names></name><name><surname>Iijima</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>WJ</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Yu</surname> <given-names>K</given-names></name><name><surname>Lee</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>JNK/FOXO-mediated neuronal expression of fly homologue of peroxiredoxin II reduces oxidative stress and extends life span</article-title><source>Journal of Biological Chemistry</source><volume>284</volume><fpage>29454</fpage><lpage>29461</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.028027</pub-id><pub-id pub-id-type="pmid">19720829</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leichert</surname> <given-names>LI</given-names></name><name><surname>Dick</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Incidence and physiological relevance of protein thiol switches</article-title><source>Biological Chemistry</source><volume>396</volume><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1515/hsz-2014-0314</pub-id><pub-id pub-id-type="pmid">25719318</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>SJ</given-names></name><name><surname>Defossez</surname> <given-names>PA</given-names></name><name><surname>Guarente</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Requirement of NAD and SIR2 for life-span extension by calorie restriction in <italic>Saccharomyces cerevisiae</italic></article-title><source>Science</source><volume>289</volume><fpage>2126</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.1126/science.289.5487.2126</pub-id><pub-id pub-id-type="pmid">11000115</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname> <given-names>VD</given-names></name><name><surname>Shadel</surname> <given-names>GS</given-names></name><name><surname>Kaeberlein</surname> <given-names>M</given-names></name><name><surname>Kennedy</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Replicative and chronological aging in <italic>Saccharomyces cerevisiae</italic></article-title><source>Cell Metabolism</source><volume>16</volume><fpage>18</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2012.06.002</pub-id><pub-id pub-id-type="pmid">22768836</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longtine</surname> <given-names>MS</given-names></name><name><surname>McKenzie</surname> <given-names>A</given-names></name><name><surname>Demarini</surname> <given-names>DJ</given-names></name><name><surname>Shah</surname> <given-names>NG</given-names></name><name><surname>Wach</surname> <given-names>A</given-names></name><name><surname>Brachat</surname> <given-names>A</given-names></name><name><surname>Philippsen</surname> <given-names>P</given-names></name><name><surname>Pringle</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Additional modules for versatile and economical PCR-based gene deletion and modification in <italic>Saccharomyces cerevisiae</italic></article-title><source>Yeast</source><volume>14</volume><fpage>953</fpage><lpage>961</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1097-0061(199807)14:10&lt;953::AID-YEA293&gt;3.0.CO;2-U</pub-id><pub-id pub-id-type="pmid">9717241</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maillet</surname> <given-names>I</given-names></name><name><surname>Lagniel</surname> <given-names>G</given-names></name><name><surname>Perrot</surname> <given-names>M</given-names></name><name><surname>Boucherie</surname> <given-names>H</given-names></name><name><surname>Labarre</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Rapid identification of yeast proteins on two-dimensional gels</article-title><source>Journal of Biological Chemistry</source><volume>271</volume><fpage>10263</fpage><lpage>10270</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.17.10263</pub-id><pub-id pub-id-type="pmid">8626593</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mashhoon</surname> <given-names>N</given-names></name><name><surname>Carmel</surname> <given-names>G</given-names></name><name><surname>Pflugrath</surname> <given-names>JW</given-names></name><name><surname>Kuret</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Structure of the unliganded cAMP-dependent protein kinase catalytic subunit from <italic>Saccharomyces cerevisiae</italic></article-title><source>Archives of Biochemistry and Biophysics</source><volume>387</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1006/abbi.2000.2241</pub-id><pub-id pub-id-type="pmid">11368172</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattison</surname> <given-names>JA</given-names></name><name><surname>Colman</surname> <given-names>RJ</given-names></name><name><surname>Beasley</surname> <given-names>TM</given-names></name><name><surname>Allison</surname> <given-names>DB</given-names></name><name><surname>Kemnitz</surname> <given-names>JW</given-names></name><name><surname>Roth</surname> <given-names>GS</given-names></name><name><surname>Ingram</surname> <given-names>DK</given-names></name><name><surname>Weindruch</surname> <given-names>R</given-names></name><name><surname>de Cabo</surname> <given-names>R</given-names></name><name><surname>Anderson</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Caloric restriction improves health and survival of rhesus monkeys</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>14063</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms14063</pub-id><pub-id pub-id-type="pmid">28094793</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Renault</surname> <given-names>JP</given-names></name><name><surname>Lagniel</surname> <given-names>G</given-names></name><name><surname>Pin</surname> <given-names>S</given-names></name><name><surname>Toledano</surname> <given-names>M</given-names></name><name><surname>Labarre</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ionizing radiation induces a Yap1-dependent peroxide stress response in yeast</article-title><source>Free Radical Biology and Medicine</source><volume>43</volume><fpage>136</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.04.007</pub-id><pub-id pub-id-type="pmid">17561102</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Hanzén</surname> <given-names>S</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name><name><surname>Labarre</surname> <given-names>J</given-names></name><name><surname>Nyström</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Life span extension and H(2)O(2) resistance elicited by caloric restriction require the peroxiredoxin Tsa1 in <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular Cell</source><volume>43</volume><fpage>823</fpage><lpage>833</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2011.07.027</pub-id><pub-id pub-id-type="pmid">21884982</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Logg</surname> <given-names>K</given-names></name><name><surname>Bodvard</surname> <given-names>K</given-names></name><name><surname>Peeters</surname> <given-names>K</given-names></name><name><surname>Forsmark</surname> <given-names>A</given-names></name><name><surname>Roger</surname> <given-names>F</given-names></name><name><surname>Blomberg</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Protein kinase A controls the multifaceted biology of growth in visible light</article-title><source>BMC Biology</source><comment>In press</comment></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Demir</surname> <given-names>AB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Linking peroxiredoxin and Vacuolar-ATPase functions in calorie Restriction-Mediated life span extension</article-title><source>International Journal of Cell Biology</source><volume>2014</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1155/2014/913071</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>CA</given-names></name><name><surname>Krause</surname> <given-names>DS</given-names></name><name><surname>Carman</surname> <given-names>CV</given-names></name><name><surname>Das</surname> <given-names>S</given-names></name><name><surname>Dubey</surname> <given-names>DP</given-names></name><name><surname>Abraham</surname> <given-names>JL</given-names></name><name><surname>Bronson</surname> <given-names>RT</given-names></name><name><surname>Fujiwara</surname> <given-names>Y</given-names></name><name><surname>Orkin</surname> <given-names>SH</given-names></name><name><surname>Van Etten</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression</article-title><source>Nature</source><volume>424</volume><fpage>561</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1038/nature01819</pub-id><pub-id pub-id-type="pmid">12891360</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noichri</surname> <given-names>Y</given-names></name><name><surname>Palais</surname> <given-names>G</given-names></name><name><surname>Ruby</surname> <given-names>V</given-names></name><name><surname>D'Autreaux</surname> <given-names>B</given-names></name><name><surname>Delaunay-Moisan</surname> <given-names>A</given-names></name><name><surname>Nyström</surname> <given-names>T</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Toledano</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>In vivo parameters influencing 2-Cys prx oligomerization: the role of enzyme sulfinylation</article-title><source>Redox Biology</source><volume>6</volume><fpage>326</fpage><lpage>333</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2015.08.011</pub-id><pub-id pub-id-type="pmid">26335398</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyström</surname> <given-names>T</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Peroxiredoxins, gerontogenes linking aging to genome instability and Cancer</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>2001</fpage><lpage>2008</lpage><pub-id pub-id-type="doi">10.1101/gad.200006.112</pub-id><pub-id pub-id-type="pmid">22987634</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oláhová</surname> <given-names>M</given-names></name><name><surname>Veal</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A peroxiredoxin, PRDX-2, is required for insulin secretion and insulin/IIS-dependent regulation of stress resistance and longevity</article-title><source>Aging Cell</source><volume>14</volume><fpage>558</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1111/acel.12321</pub-id><pub-id pub-id-type="pmid">25808059</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parrinello</surname> <given-names>M</given-names></name><name><surname>Rahman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Polymorphic transitions in single crystals: a new molecular dynamics method</article-title><source>Journal of Applied Physics</source><volume>52</volume><fpage>7182</fpage><lpage>7190</lpage><pub-id pub-id-type="doi">10.1063/1.328693</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parts</surname> <given-names>L</given-names></name><name><surname>Cubillos</surname> <given-names>FA</given-names></name><name><surname>Warringer</surname> <given-names>J</given-names></name><name><surname>Jain</surname> <given-names>K</given-names></name><name><surname>Salinas</surname> <given-names>F</given-names></name><name><surname>Bumpstead</surname> <given-names>SJ</given-names></name><name><surname>Molin</surname> <given-names>M</given-names></name><name><surname>Zia</surname> <given-names>A</given-names></name><name><surname>Simpson</surname> <given-names>JT</given-names></name><name><surname>Quail</surname> <given-names>MA</given-names></name><name><surname>Moses</surname> <given-names>A</given-names></name><name><surname>Louis</surname> <given-names>EJ</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><name><surname>Liti</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Revealing the genetic structure of a trait by sequencing a population under selection</article-title><source>Genome Research</source><volume>21</volume><fpage>1131</fpage><lpage>1138</lpage><pub-id pub-id-type="doi">10.1101/gr.116731.110</pub-id><pub-id pub-id-type="pmid">21422276</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peeters</surname> <given-names>K</given-names></name><name><surname>Van Leemputte</surname> <given-names>F</given-names></name><name><surname>Fischer</surname> <given-names>B</given-names></name><name><surname>Bonini</surname> <given-names>BM</given-names></name><name><surname>Quezada</surname> <given-names>H</given-names></name><name><surname>Tsytlonok</surname> <given-names>M</given-names></name><name><surname>Haesen</surname> <given-names>D</given-names></name><name><surname>Vanthienen</surname> <given-names>W</given-names></name><name><surname>Bernardes</surname> <given-names>N</given-names></name><name><surname>Gonzalez-Blas</surname> <given-names>CB</given-names></name><name><surname>Janssens</surname> <given-names>V</given-names></name><name><surname>Tompa</surname> <given-names>P</given-names></name><name><surname>Versées</surname> <given-names>W</given-names></name><name><surname>Thevelein</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fructose-1,6-bisphosphate couples glycolytic flux to activation of ras</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>922</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-01019-z</pub-id><pub-id pub-id-type="pmid">29030545</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponder</surname> <given-names>JW</given-names></name><name><surname>Case</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Force fields for protein simulations</article-title><source>Advances in Protein Chemistry</source><volume>66</volume><fpage>27</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/s0065-3233(03)66002-x</pub-id><pub-id pub-id-type="pmid">14631816</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rappsilber</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Ishihama</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips</article-title><source>Nature Protocols</source><volume>2</volume><fpage>1896</fpage><lpage>1906</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.261</pub-id><pub-id pub-id-type="pmid">17703201</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname> <given-names>W</given-names></name><name><surname>Anrather</surname> <given-names>D</given-names></name><name><surname>Dohnal</surname> <given-names>I</given-names></name><name><surname>Pichler</surname> <given-names>P</given-names></name><name><surname>Veis</surname> <given-names>J</given-names></name><name><surname>Grøtli</surname> <given-names>M</given-names></name><name><surname>Posas</surname> <given-names>F</given-names></name><name><surname>Ammerer</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Validation of regulated protein phosphorylation events in yeast by quantitative mass spectrometry analysis of purified proteins</article-title><source>Proteomics</source><volume>12</volume><fpage>3030</fpage><lpage>3043</lpage><pub-id pub-id-type="doi">10.1002/pmic.201200185</pub-id><pub-id pub-id-type="pmid">22890988</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santangelo</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Glucose signaling in <italic>Saccharomyces cerevisiae</italic></article-title><source>Microbiology and Molecular Biology Reviews</source><volume>70</volume><fpage>253</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1128/MMBR.70.1.253-282.2006</pub-id><pub-id pub-id-type="pmid">16524925</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname> <given-names>TJ</given-names></name><name><surname>Zarse</surname> <given-names>K</given-names></name><name><surname>Voigt</surname> <given-names>A</given-names></name><name><surname>Urban</surname> <given-names>N</given-names></name><name><surname>Birringer</surname> <given-names>M</given-names></name><name><surname>Ristow</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Glucose restriction <italic>extends Caenorhabditis elegans</italic> life span by inducing mitochondrial respiration and increasing oxidative stress</article-title><source>Cell Metabolism</source><volume>6</volume><fpage>280</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.08.011</pub-id><pub-id pub-id-type="pmid">17908557</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname> <given-names>DA</given-names></name><name><surname>Guarente</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Extrachromosomal rDNA circles--a cause of aging in yeast</article-title><source>Cell</source><volume>91</volume><fpage>1033</fpage><lpage>1042</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80493-6</pub-id><pub-id pub-id-type="pmid">9428525</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjölander</surname> <given-names>JJ</given-names></name><name><surname>Tarczykowska</surname> <given-names>A</given-names></name><name><surname>Cossio</surname> <given-names>I</given-names></name><name><surname>Redwan</surname> <given-names>N</given-names></name><name><surname>Corap</surname> <given-names>S</given-names></name><name><surname>Gao</surname> <given-names>C</given-names></name><name><surname>Sunnerhagen</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Enhanced MAPK peroxide signalling by a small molecule protecting fission yeast MAPKK Wis1 from inhibitory thiol oxidation</article-title><source>Molecular and Cellular Biology</source><volume>40</volume><elocation-id>e00346</elocation-id><pub-id pub-id-type="doi">10.1128/MCB.00346-19</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Yeast PKA represses Msn2p/Msn4p-dependent gene expression to regulate growth, stress response and glycogen accumulation</article-title><source>The EMBO Journal</source><volume>17</volume><fpage>3556</fpage><lpage>3564</lpage><pub-id pub-id-type="doi">10.1093/emboj/17.13.3556</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sohal</surname> <given-names>RS</given-names></name><name><surname>Forster</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Caloric restriction and the aging process: a critique</article-title><source>Free Radical Biology and Medicine</source><volume>73</volume><fpage>366</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.05.015</pub-id><pub-id pub-id-type="pmid">24941891</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stöcker</surname> <given-names>S</given-names></name><name><surname>Van Laer</surname> <given-names>K</given-names></name><name><surname>Mijuskovic</surname> <given-names>A</given-names></name><name><surname>Dick</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>The conundrum of hydrogen peroxide signaling and the emerging role of peroxiredoxins as redox relay hubs</article-title><source>Antioxidants &amp; Redox Signaling</source><volume>28</volume><fpage>558</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1089/ars.2017.7162</pub-id><pub-id pub-id-type="pmid">28587525</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stöcker</surname> <given-names>S</given-names></name><name><surname>Maurer</surname> <given-names>M</given-names></name><name><surname>Ruppert</surname> <given-names>T</given-names></name><name><surname>Dick</surname> <given-names>TP</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>A role for 2-Cys peroxiredoxins in facilitating cytosolic protein thiol oxidation</article-title><source>Nature Chemical Biology</source><volume>14</volume><fpage>148</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2536</pub-id><pub-id pub-id-type="pmid">29251718</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagwerker</surname> <given-names>C</given-names></name><name><surname>Flick</surname> <given-names>K</given-names></name><name><surname>Cui</surname> <given-names>M</given-names></name><name><surname>Guerrero</surname> <given-names>C</given-names></name><name><surname>Dou</surname> <given-names>Y</given-names></name><name><surname>Auer</surname> <given-names>B</given-names></name><name><surname>Baldi</surname> <given-names>P</given-names></name><name><surname>Huang</surname> <given-names>L</given-names></name><name><surname>Kaiser</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A tandem affinity tag for two-step purification under fully denaturing conditions: application in ubiquitin profiling and protein complex identification combined with in vivocross-linking</article-title><source>Molecular &amp; Cellular Proteomics : MCP</source><volume>5</volume><fpage>737</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1074/mcp.M500368-MCP200</pub-id><pub-id pub-id-type="pmid">16432255</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toda</surname> <given-names>T</given-names></name><name><surname>Uno</surname> <given-names>I</given-names></name><name><surname>Ishikawa</surname> <given-names>T</given-names></name><name><surname>Powers</surname> <given-names>S</given-names></name><name><surname>Kataoka</surname> <given-names>T</given-names></name><name><surname>Broek</surname> <given-names>D</given-names></name><name><surname>Cameron</surname> <given-names>S</given-names></name><name><surname>Broach</surname> <given-names>J</given-names></name><name><surname>Matsumoto</surname> <given-names>K</given-names></name><name><surname>Wigler</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>In yeast, RAS proteins are controlling elements of adenylate cyclase</article-title><source>Cell</source><volume>40</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(85)90305-8</pub-id><pub-id pub-id-type="pmid">2981630</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname> <given-names>TH</given-names></name><name><surname>Carroll</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bioorthogonal chemical reporters for analyzing protein sulfenylation in cells</article-title><source>Current Protocols in Chemical Biology</source><volume>4</volume><fpage>101</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/9780470559277.ch110219</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizcaíno</surname> <given-names>JA</given-names></name><name><surname>Csordas</surname> <given-names>A</given-names></name><name><surname>del-Toro</surname> <given-names>N</given-names></name><name><surname>Dianes</surname> <given-names>JA</given-names></name><name><surname>Griss</surname> <given-names>J</given-names></name><name><surname>Lavidas</surname> <given-names>I</given-names></name><name><surname>Mayer</surname> <given-names>G</given-names></name><name><surname>Perez-Riverol</surname> <given-names>Y</given-names></name><name><surname>Reisinger</surname> <given-names>F</given-names></name><name><surname>Ternent</surname> <given-names>T</given-names></name><name><surname>Xu</surname> <given-names>QW</given-names></name><name><surname>Wang</surname> <given-names>R</given-names></name><name><surname>Hermjakob</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>2016 update of the PRIDE database and its related tools</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D447</fpage><lpage>D456</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1145</pub-id><pub-id pub-id-type="pmid">26527722</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>RB</given-names></name><name><surname>Tatchell</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>SRA5 encodes the low-Km cyclic AMP phosphodiesterase of <italic>Saccharomyces cerevisiae</italic></article-title><source>Molecular and Cellular Biology</source><volume>8</volume><fpage>505</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1128/MCB.8.1.505</pub-id><pub-id pub-id-type="pmid">2827010</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname> <given-names>HA</given-names></name><name><surname>Yim</surname> <given-names>SH</given-names></name><name><surname>Shin</surname> <given-names>DH</given-names></name><name><surname>Kang</surname> <given-names>D</given-names></name><name><surname>Yu</surname> <given-names>DY</given-names></name><name><surname>Rhee</surname> <given-names>SG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling</article-title><source>Cell</source><volume>140</volume><fpage>517</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.01.009</pub-id><pub-id pub-id-type="pmid">20178744</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Gupta</surname> <given-names>V</given-names></name><name><surname>Tallman</surname> <given-names>KA</given-names></name><name><surname>Porter</surname> <given-names>NA</given-names></name><name><surname>Carroll</surname> <given-names>KS</given-names></name><name><surname>Liebler</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Global, in situ, site-specific analysis of protein S-sulfenylation</article-title><source>Nature Protocols</source><volume>10</volume><fpage>1022</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.062</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname> <given-names>Y</given-names></name><name><surname>Tsuchiyama</surname> <given-names>S</given-names></name><name><surname>Yang</surname> <given-names>C</given-names></name><name><surname>Bulteau</surname> <given-names>AL</given-names></name><name><surname>He</surname> <given-names>C</given-names></name><name><surname>Robison</surname> <given-names>B</given-names></name><name><surname>Tsuchiya</surname> <given-names>M</given-names></name><name><surname>Miller</surname> <given-names>D</given-names></name><name><surname>Briones</surname> <given-names>V</given-names></name><name><surname>Tar</surname> <given-names>K</given-names></name><name><surname>Potrero</surname> <given-names>A</given-names></name><name><surname>Friguet</surname> <given-names>B</given-names></name><name><surname>Kennedy</surname> <given-names>BK</given-names></name><name><surname>Schmidt</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Proteasomes, Sir2, and Hxk2 form an interconnected aging network that impinges on the AMPK/Snf1-regulated transcriptional repressor Mig1</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1004968</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004968</pub-id><pub-id pub-id-type="pmid">25629410</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Smith-Nguyen</surname> <given-names>EV</given-names></name><name><surname>Keshwani</surname> <given-names>MM</given-names></name><name><surname>Deal</surname> <given-names>MS</given-names></name><name><surname>Kornev</surname> <given-names>AP</given-names></name><name><surname>Taylor</surname> <given-names>SS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Structure and allostery of the PKA riiβ tetrameric holoenzyme</article-title><source>Science</source><volume>335</volume><fpage>712</fpage><lpage>716</lpage><pub-id pub-id-type="doi">10.1126/science.1213979</pub-id><pub-id pub-id-type="pmid">22323819</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>N</given-names></name><name><surname>Quan</surname> <given-names>Z</given-names></name><name><surname>Rash</surname> <given-names>B</given-names></name><name><surname>Oliver</surname> <given-names>SG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Synergistic effects of TOR and proteasome pathways on the yeast transcriptome and cell growth</article-title><source>Open Biology</source><volume>3</volume><elocation-id>120137</elocation-id><pub-id pub-id-type="doi">10.1098/rsob.120137</pub-id><pub-id pub-id-type="pmid">23697803</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Ye</surname> <given-names>Z-W</given-names></name><name><surname>Singh</surname> <given-names>S</given-names></name><name><surname>Townsend</surname> <given-names>DM</given-names></name><name><surname>Tew</surname> <given-names>KD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>An evolving understanding of the S-glutathionylation cycle in pathways of redox regulation</article-title><source>Free Radical Biology and Medicine</source><volume>120</volume><fpage>204</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.03.038</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>K</given-names></name><name><surname>Borrelli</surname> <given-names>KW</given-names></name><name><surname>Greenwood</surname> <given-names>JR</given-names></name><name><surname>Day</surname> <given-names>T</given-names></name><name><surname>Abel</surname> <given-names>R</given-names></name><name><surname>Farid</surname> <given-names>RS</given-names></name><name><surname>Harder</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Docking covalent inhibitors: a parameter free approach to pose prediction and scoring</article-title><source>Journal of Chemical Information and Modeling</source><volume>54</volume><fpage>1932</fpage><lpage>1940</lpage><pub-id pub-id-type="doi">10.1021/ci500118s</pub-id><pub-id pub-id-type="pmid">24916536</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60346.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Schuldiner</surname><given-names>Maya</given-names></name><role>Reviewing Editor</role><aff><institution>Weizmann Institute</institution><country>Israel</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>The manuscript is a beautiful example of yeast genetics – shedding mechanistic light on a highly conserved and extremely important response pathway affecting life- and health-span. Specifically it uncovers the mechanism by which the peroxiredoxin Tsa1 improves longevity and H<sub>2</sub>O<sub>2</sub> tolerance. The exciting finding is that Tsa1 promotes</p><p>both H<sub>2</sub>O<sub>2</sub> tolerance and lifespan extension not through its well-studied role as an H<sub>2</sub>O<sub>2</sub> cavenger, but by signaling towards PKA. These findings create a much richer view of peroxiredoxins – studied for over 25 years – showing that these enzymes have important roles beyond their H<sub>2</sub>O<sub>2</sub> scavenging function.</p><p><bold>Decision letter after peer review:</bold></p><p>[Editors’ note: the authors submitted for reconsideration following the decision after peer review. What follows is the decision letter after the first round of review.]</p><p>Thank you for submitting your work entitled &quot;Peroxiredoxin promotes longevity and H<sub>2</sub>O<sub>2</sub>-resistance in yeast through redox-modulation of protein kinase A&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Senior Editor. The reviewers have opted to remain anonymous.</p><p>Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in <italic>eLife</italic>. Please find the combined reasons for this as well as suggestions for improvements for future submissions below.</p><p>Combined Reviews:</p><p>The manuscript by Roger et al. aims to identify specific targets of nutrient signaling explaining the beneficial effects of Caloric Restriction (CR). They focus on the yeast peroxiredoxin Tsa1, which they have previously shown is stimulated by CR and required for the increase in both H<sub>2</sub>O<sub>2</sub> tolerance and lifespan. They set out to uncover whether Tsa1 performs this role by reducing H<sub>2</sub>O<sub>2</sub> levels or rather by acting as a signaling molecule. They suggest that in the context of CR, Tsa1 works through its function on PKA, which it regulates by modifying a conserved cysteine in the most highly expressed PKA catalytic subunit.</p><p>In our eyes the authors provide compelling evidence that Tsa1's overexpression phenotype of lifespan extension and recovery of cells from H<sub>2</sub>O<sub>2</sub> challenges is because of its ability to regulate Protein Kinase A activity. The finding that Tsa1 mediates its effect through PKA identifies a previously unappreciated mechanism of redox state regulation of PKA. Interestingly, while the authors work is in yeast, the sites of modification on PKA that are mediated by Tsa1 are conserved. This suggests that this mechanism of action is also conserved and should impact how the aging and redox fields consider ROS and its effect on aging.</p><p>However, there were some major concerns raised that lead us to reject this manuscript:</p><p>1) The function of Tsa1 through PKA was already partially shown in Bodvard et al., 2017.</p><p>2) The manuscript claims that Tsa1 modulates the redox state of Tpk1 cysteines, however, no direct evidence is provided. There is no data that would demonstrate a Tsa1-Tpk1 interaction. It is not clear what kind of redox mechanism is actually proposed by the authors. Tsa1 directly oxidizing Tpk1? What is the role of Trxs? How does glutathione fit in here? There is also no discussion addressing these issues.</p><p>3) There doesn't seem to be a clear experiment that properly shows that the absence of Tsa1 results in a different Tpk1 redox state. The absence of Tsa1 does not seem to affect Tpk1 glutathionylation in the absence of exogenously applied H<sub>2</sub>O<sub>2</sub> (Figure 6I). The PEGylation experiments were done with the addition of exogenous H<sub>2</sub>O<sub>2</sub>, and PEGylation was still observed with the C243A mutant. The connection between glutathionylation of a protein and peroxiredoxin activity (which is normally coupled to the Trx system and not to the GSH/Grx system), if true, remains very much unclear.</p><p>4) The only piece of evidence suggesting that the cysteine residues of Tpk1 are important seems to be Figure 6G. Here, and only within the context of the <italic>tpk1Δtpk2Δtpk3Δ</italic> triple deletion, the authors show a lower resistance to H<sub>2</sub>O<sub>2</sub>. Like in some other places, the information about the specifics of the experiments seem to be incomplete. Here, it is not clear how resistance was determined. Is it from a spot test? Is it from a viability assay? How much H<sub>2</sub>O<sub>2</sub> was added? What were the conditions? There is no control showing that Tpk1 C243A is expressed at the same level as Tpk1wt.</p><p>5) Although a lot of weight is put on the determination that Tsa1 acts independently of H<sub>2</sub>O<sub>2</sub> scavenging, it is not clear if and how the data shown in Figure 1 can actually demonstrate this. Cells lacking individual thiol peroxidases usually adapt to adjust their overall reductive capacity, thus it is not surprising that they do not exhibit differences in the overall H<sub>2</sub>O<sub>2</sub> uptake rate or in the average redox state of cytosolic Hyper3. But redox control can be highly localized and Tsa1 may still locally control exposure of Tpx1 to H<sub>2</sub>O<sub>2</sub> by acting as a scavenger. The involvement of Trxs in the process would rather speak in favor of a scavenging scenario.</p><p>6) Finally, some of the data shown in Figure 4A seem to be taken from a data set that was already published: Figure 1A in Hanzen et al., 2016; this is not explicitly indicated as far as I can see.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.60346.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Combined Reviews:</p><p>The manuscript by Roger et al. aims to identify specific targets of nutrient signaling explaining the beneficial effects of Caloric Restriction (CR). They focus on the yeast peroxiredoxin Tsa1, which they have previously shown is stimulated by CR and required for the increase in both H<sub>2</sub>O<sub>2</sub> tolerance and lifespan. They set out to uncover whether Tsa1 performs this role by reducing H<sub>2</sub>O<sub>2</sub> levels or rather by acting as a signaling molecule. They suggest that in the context of CR, Tsa1 works through its function on PKA, which it regulates by modifying a conserved cysteine in the most highly expressed PKA catalytic subunit.</p><p>In our eyes the authors provide compelling evidence that Tsa1's overexpression phenotype of lifespan extension and recovery of cells from H<sub>2</sub>O<sub>2</sub> challenges is because of its ability to regulate Protein Kinase A activity. The finding that Tsa1 mediates its effect through PKA identifies a previously unappreciated mechanism of redox state regulation of PKA. Interestingly, while the authors work is in yeast, the sites of modification on PKA that are mediated by Tsa1 are conserved. This suggests that this mechanism of action is also conserved and should impact how the aging and redox fields consider ROS and its effect on aging.</p><p>However, there were some major concerns raised that lead us to reject this manuscript:</p><p>1) The function of Tsa1 through PKA was already partially shown in Bodvard et al., 2017.</p></disp-quote><p>We indeed previously showed that Tsa1 impacts on PKA-dependent phosphorylation of the transcription factor Msn2 by H<sub>2</sub>O<sub>2</sub>, which indirectly made inferences on the activity of PKA. However, the focus of the two studies is totally different: the Bodvard et al. study enquired about the activation of the Msn2 transcription factor in response to light and H<sub>2</sub>O<sub>2</sub>, whereas in the current paper, emphasis is on longevity, H<sub>2</sub>O<sub>2</sub> tolerance, only using the Msn2 response as readout of PKA activity amongst many others. Furthermore, the main conclusions reached in the new study are totally new and provocative, as described below, also addressing for the first time the mechanism by which Tsa1 represses PKA:</p><p>1) Our main conclusion that Tsa1 promotes yeast H2O2 tolerance and lifespan extension not as an H<sub>2</sub>O<sub>2</sub> scavenger, but by signaling towards PKA (see below) is new and a highly provocative concept, shaking up ~25 years of research on peroxiredoxins since their discovery indicating that these enzymes promote H<sub>2</sub>O<sub>2</sub> tolerance by their enzymatic H<sub>2</sub>O<sub>2</sub> scavenging function.</p><p>2) We provide genetic and mechanistic information on this regulation both regarding the exact target of Tsa1 in the PKA pathway, PKA itself, and the Tsa1 biochemical function effecting this response. In the previous study we only indirectly inferred of the impact of Tsa1 on PKA through the specific pattern of Msn2 phosphorylation.</p><p>3) Furthermore, we show how the identified Tsa1 biochemical function interferes with PKA, by signaling through its interaction with a PKA catalytic subunit (Tpk1) and promotion of PKA Cys residue sulfenylation in response to H<sub>2</sub>O<sub>2</sub>.</p><p>4) We also identify a Tpk1 Cys residue in the kinase activation loop that is conserved in all eukaryotic PKA enzymes, and is required for Tsa1-mediated H<sub>2</sub>O<sub>2</sub>-resistance.</p><disp-quote content-type="editor-comment"><p>2) The manuscript claims that Tsa1 modulates the redox state of Tpk1 cysteines, however, no direct evidence is provided. There is no data that would demonstrate a Tsa1-Tpk1 interaction. It is not clear what kind of redox mechanism is actually proposed by the authors. Tsa1 directly oxidizing Tpk1? What is the role of Trxs? How does glutathione fit in here? There is also no discussion addressing these issues.</p><p>3) There doesn't seem to be a clear experiment that properly shows that the absence of Tsa1 results in a different Tpk1 redox state. The absence of Tsa1 does not seem to affect Tpk1 glutathionylation in the absence of exogenously applied H<sub>2</sub>O<sub>2</sub> (Figure 6I).</p></disp-quote><p>The previous submission provided data showing that Tsa1 regulates Tpk1 deglutathionylation. In the current, revised submission, we now provide evidence of a (i) direct interaction of Tsa1 and Tpk1 by coimmunoprecipitation and (ii) that Tpk1 becomes sulfenylated in response to H<sub>2</sub>O<sub>2</sub> in a manner dependent on Tsa1. (iii) We also confirm that Tpk1 is glutathionylated, and that this modification decreases with H<sub>2</sub>O<sub>2</sub>, although we have so far failed modeling the redox mechanism modulating PKA. (iv) We have also thoroughly addressed the role of thioredoxins, both genetically and biochemically, and came to the conclusion that these enzymes are only very partially involved in PKA repression, which departs from the Bodvard et al. study, again indicating that although PKA is a target of repression in both studies, other signaling pathways at play differentiate these studies. (v) We are still short of a solid model of Tpk1 redox regulation, and thus have now thoroughly discussed the possible redox mechanism at play in Tpk1 repression and in particular how to reconcile Tpk1 deglutathionylation and sulfenylation in response to H<sub>2</sub>O<sub>2</sub>. Our belief is that Tpk1 sulfenylation is the driving event in Tpk1 inactivation, a question left at the appreciation of the reviewers.</p><p>The new data encompasses four new main figure panels and two figure supplement panels: Figure 4A and Figure 4—figure supplement 1A, addressing point (i) above; Figure 4D and Figure 4—figure supplement 1I, addressing point (ii) and Figures 2J and 3E addressing point (iv). We discuss these new data in subsections “Tsa1 catalytic cysteines control H2O2 resistance by repressing PKA” and “Tpk1 is sulfenylated upon H2O2 addition and glutathionylated on the conserved Cys243”. Relating to point (v) we updated the Discussion with a thorough review of possible redox mechanisms at play in paragraph three.</p><disp-quote content-type="editor-comment"><p>The PEGylation experiments were done with the addition of exogenous H<sub>2</sub>O<sub>2</sub>, and PEGylation was still observed with the C243A mutant.</p></disp-quote><p>We accept this criticism. Mal-PEG experiments are often hard to interpret and therefore we removed this experiment.</p><disp-quote content-type="editor-comment"><p>The connection between glutathionylation of a protein and peroxiredoxin activity (which is normally coupled to the Trx system and not to the GSH/Grx system), if true, remains very much unclear.</p></disp-quote><p>We totally agree with this statement. Our data do not suggest this eventuality, since Tpk1 glutathionylation is seen in cells lacking Tsa1, even more so than in wild type cells. We have clarified our view in the Results section, and have discussed how glutathionylation might happen in the context of our new data showing Tpk1 sulfenylation.</p><disp-quote content-type="editor-comment"><p>4) The only piece of evidence suggesting that the cysteine residues of Tpk1 are important seems to be Figure 6G. Here, and only within the context of the tpk1Δtpk2Δtpk3Δ triple deletion, the authors show a lower resistance to H<sub>2</sub>O<sub>2</sub>. Like in some other places, the information about the specifics of the experiments seem to be incomplete. Here, it is not clear how resistance was determined. Is it from a spot test? Is it from a viability assay? How much H<sub>2</sub>O<sub>2</sub> was added? What were the conditions? There is no control showing that Tpk1 C243A is expressed at the same level as Tpk1wt.</p></disp-quote><p>We take this fair criticism that we have now addressed in several ways in the revised manuscript:</p><p>1) A special section in Materials and methods describes the H<sub>2</sub>O<sub>2</sub> spot tests experiments.</p><p>2) We have edited the figures and legends of all spot-test experiments, specifying the concentration H<sub>2</sub>O<sub>2</sub>.</p><p>3) We now provide western blot data on Tpk1 protein levels (Figure 5—figure supplement 1D).</p><disp-quote content-type="editor-comment"><p>5) Although a lot of weight is put on the determination that Tsa1 acts independently of H<sub>2</sub>O<sub>2</sub> scavenging, it is not clear if and how the data shown in Figure 1 can actually demonstrate this. Cells lacking individual thiol peroxidases usually adapt to adjust their overall reductive capacity, thus it is not surprising that they do not exhibit differences in the overall H<sub>2</sub>O<sub>2</sub> uptake rate or in the average redox state of cytosolic Hyper3. But redox control can be highly localized and Tsa1 may still locally control exposure of Tpx1 to H<sub>2</sub>O<sub>2</sub> by acting as a scavenger. The involvement of Trxs in the process would rather speak in favor of a scavenging scenario.</p></disp-quote><p>The reviewer comment is totally correct by saying that cells adapt to the loss of a gene by many ways. However, she/he is missing the fact that the same cells that lack Tsa1 display a loss of H<sub>2</sub>O<sub>2</sub> tolerance as seen by spot assay, a phenotype that should not be seen if indeed these cells had adapted. Therefore, these experiments can only be interpreted by confronting the results of the spot sensitivity assay against both the ability of cells to clear a bolus of H<sub>2</sub>O<sub>2</sub> in the medium and the cellular levels of H<sub>2</sub>O<sub>2</sub> measured with the hypersensitive HyPer3 probe.</p><p>Anyhow, that the conclusion that Tsa1 H<sub>2</sub>O<sub>2</sub> tolerance phenotype is not a function of its scavenging activity is built on the body of evidences provided in the paper, including this experiment and the total rescue of the <italic>tsa1Δ</italic> H<sub>2</sub>O<sub>2</sub> phenotype by deletion of <italic>RAS2</italic>.</p><disp-quote content-type="editor-comment"><p>6) Finally, some of the data shown in Figure 4A seem to be taken from a data set that was already published: Figure 1A in Hanzen et al., 2016; this is not explicitly indicated as far as I can see.</p></disp-quote><p>We have now replaced the data provided with the experiment-matched controls used in determining <italic>pde2Δ</italic> control and <italic>pde2Δ</italic> o/e <italic>TSA1</italic> life-spans.</p></body></sub-article></article>